UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2016

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 333-167380

PFO GLOBAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada		65-0434332
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

14401 Beltwood Parkway, Suite 115, Farmers Branch, TX 75244

(972) 573-6135

(Address including zip code, and telephone number, including area code, of principal executive offices)

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days*. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☒
Non-Accelerated Filer	☐	Smaller reporting company	☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~August~~November 227, 2016 there were 20,917,506 shares of the registrant's common stock, par value $0.0001 per share, outstanding, including 23.988 shares of preferred stock convertible into 2,500,000 shares of common stock, on an as is converted basis.

* The registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, but is not required to file such reports under such sections.

TABLE OF CONTENTS

		Page
	PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3233
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	4546
Item 4.	Controls and Procedures	4647
	PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	4748
Item 1A.	Risk Factors	4748
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 3.	Defaults Upon Securities	48
Item 4.	Mine Safety Disclosure	48
Item 5.	Other Information	48
Item 6.	Exhibits	48
SIGNATURES		4849

PART I

Item 1.

Condensed Consolidated Financial Statements

PFO Global, inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2016			December 31, 2015
	September 30, 2016			December 31, 2015
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	33130,~~056~~413		$	26,250
Accounts receivable		~~336~~362,~~328~~322			485,192
Inventories		~~592~~721,~~351~~072			724,009
Prepaid expenses and other assets		3716,~~460~~703			104,546
Total current assets		~~999~~1,~~195~~230,510			1,339,997
Property and equipment, net		77117,~~168~~358			152,031
Deferred costs		293,732			293,732
Other assets		110,~~363~~151			85,462
Total assets	$	1,~~480~~751,~~458~~751		$	1,871,222
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
LIABILITIES AND STOCKHOLDERS' (DEFICIT)
CURRENT LIABILITIES
Accounts payable	$	21,~~312~~963,~~003~~134		$	2,348,824
Accrued liabilities		23,~~662~~544,~~656~~537			2,145,442
Accrued interest, related parties		1,~~339~~414,~~111~~249			1,188,182
Note payable, net of discount - current portion		8,905,000			6,705,000
Note payable, related parties – current portion		2,312,761			-
Note payable, net of discount - current portion		13,532,236			6,705,000
Royalty obligation		1,750,000			1,750,000
Derivative obligation		~~1,124,391~~-			1,769,000
General unsecured claims - current portion		1310,~~569~~941			26,641
Total current liabilities		1824,~~106~~527,~~730~~858			15,933,089
Note payable, related parties - net of current portion		42,~~625~~312,~~521~~761			4,677,630
Note payable, net of discount - net of current portion		41,~~187~~532,~~484~~884			3,214,591
Deferred revenue		2,582,198			2,582,198
General unsecured claims - net of current portion		58,~~845~~655			12,662
Total long term debt		116,~~401~~436,~~048~~498			10,487,081
Total liabilities		2930,~~507~~964,~~778~~356			26,420,170
Commitments and contingencies		-			-
STOCKHOLDERS' (DEFICIT)
Preferred stock, $0.001 par value; 5,000,000 preferred shares authorized, 23.988 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively		-			-
Preferred stock, $0.001 par value; 5,000,000 preferred shares authorized, 23.988 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively		-			-
Common stock, $.0001 par value, 500,000,000 shares authorized, 18,417, 506 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively		1,842			1,842
Common stock, $.0001 par value, 500,000,000 shares authorized, 18,417, 506 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively		1,842			1,842
Additional paid in capital		9,~~283~~287,~~922~~583			9,215,458
Accumulated deficit		(3738,~~313~~502,~~084~~030	)		(33,766,248	)
Total stockholders' deficit		(2829,~~027~~212,~~320~~605	)		(24,548,948	)
Total liabilities and stockholders' deficit	$	1,~~480~~751,~~458~~751		$	1,871,222

see accompanying notes to unaudited interim Condensed Consolidated Financial Statements

PFO GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three months ended						~~Six~~Nine months ended
	June 30, 2016			June 30, 2015			June 30, 2016			June 30, 2015
	September 30, 2016			September 30, 2015			September 30, 2016			September 30, 2015
REVENUE:
Sales	$	~~920~~789,~~213~~530		$	~~787~~710,~~454~~050		$	2,~~005~~795,~~600~~130		$	12,~~771~~160,~~623~~730
COST OF GOODS SOLD (excluding depreciation shown below)		~~687~~577,~~701~~759			~~495~~508,~~359~~191			1,~~263~~840,~~000~~759			1,~~022~~530,~~277~~468
Gross profit		~~232~~211,~~512~~771			~~292~~201,~~095~~859			~~742~~954,~~600~~371			~~749~~630,~~346~~262
OPERATING EXPENSES:
Selling, general and administrative expenses		1,~~238~~337,~~769~~337			12,~~842~~242,~~017~~760			23,~~488~~826,~~748~~084			36,~~929~~172,~~349~~109
Depreciation		20,~~576~~510			5157,~~452~~900			7495,~~863~~374			~~119~~177,~~608~~508
Total operating expenses		1,~~259~~357,~~345~~847			12,~~893~~300,~~469~~660			23,~~563~~921,~~610~~458			46,~~048~~349,~~957~~617
Loss from operations		(1,~~026~~146,~~833~~076	)		(12,~~601~~098,~~374~~801	)		(12,~~821~~967,~~011~~087	)		(35,~~299~~719,~~611~~355	)
OTHER INCOME (EXPENSE):
Other income (expense)		(~~3,461~~147	)		~~(218~~71,~~055~~257	)		28,~~656~~508			~~(214~~177,~~220~~980	)
Loss on extinguishment of debt		-			~~(583,326~~-	)		-			(583,326	)
Change in fair value of derivative liabilities		~~108~~1,~~609~~124,391			(~~809~~455,~~561~~000	)		~~644~~1,~~609~~769,000			(32487,751	)
Interest expense, related parties		(72,919	)		(74,~~762~~750	)		(~~150~~223,~~929~~847	)		(~~149~~224,~~488~~238	)
Interest expense, others		(1,~~136~~094,~~893~~195	)		(1,~~281~~282,~~430~~741	)		(23,~~248~~342,~~161~~356	)		(24,~~853~~135,~~046~~787	)
Total other expense		(142,~~104,664~~870	)		(21,~~967~~741,~~134~~234	)		(1,~~725~~768,~~825~~695	)		(35,~~832~~253,~~831~~122	)
Net loss before provision for income taxes		(21,~~131~~188,~~497~~946	)		(43,~~568~~840,~~508~~035	)		(34,~~546~~735,~~836~~782	)		(710,~~132~~972,~~442~~477	)
PROVISION FOR INCOME TAXES
Income tax (benefit)		-			-			-			-
NET LOSS	$	(21,~~131~~188,~~497~~946	)	$	(43,~~568~~840,~~508~~035	)	$	(34,~~546~~735,~~836~~782	)	$	(710,~~132~~972,~~442~~477	)
Net loss per common share, basic and diluted	$	(0.1006	)	$	(0.3218	)	$	(0.1723	)	$	(0.4965	)
Weighted average number of common shares outstanding, basic and diluted		20,917,506			1420,~~491~~917,~~018~~506			20,917,506			1416,~~662~~765,~~457~~551

see accompanying notes to unaudited interim Condensed Consolidated Financial Statements

PFO GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(Unaudited)

FOR THE ~~SIX~~NINE MONTHS ENDED ~~JUNE~~SEPTEMBER 30, 2016

	Preferred Stock				Common Stock				Additional Paid in		Accumulated			Total Stockholders
	Shares		Amount		Shares		Amount		in Capital		Deficit			(Deficit)
Balance, December 31, 2015		24	$	-		18,417,506	$	1,842	$	9,215,458	$	(33,766,248	)	$	(24,548,948	)
Stock based compensation		-		-		-		-		6872,~~464~~125		-			6872,~~464~~125
Net loss		-		-		-		-		-		(34,~~546~~735,~~836~~782	)		(34,~~546~~735,~~836~~782	)
Balance, June 30, 2016		24	$	-		18,417,506	$	1,842	$	9,283,922	$	(37,313,084	)	$	(28,027,320	)
Balance, September 30, 2016		24	$	-		18,417,506	$	1,842	$	9,287,583	$	(38,502,030	)	$	(29,212,605	)

see accompanying notes to unaudited interim Condensed Consolidated Financial Statements

PFO GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

FOR THE ~~SIX~~NINE MONTHS ENDED ~~JUNE~~SEPTEMBER 30, 2016 AND 2015

	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(34,~~546~~735,~~836~~782	)	$	(710,~~132~~972,~~442~~477	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		7495,~~863~~374			~~119~~177,~~608~~508
Stock based compensation		6872,~~464~~125			228,776
Provision for doubtful accounts		~~128~~20,~~492~~672			99,520
Change in fair value of derivative liability		(~~644~~1,~~609~~769,000	)		32487,751
Interest expense, related parties		~~150~~223,~~929~~847			~~149~~224,~~488~~238
Interest expense, others		~~981~~1,~~448~~393,008			~~683~~984,~~628~~861
Amortization of debt issue costs		~~331~~501,~~753~~356			~~569~~804,~~202~~325
Amortization of debt discount		~~934~~1,~~960~~447,992			12,~~663~~346,~~898~~601
Loss on extinguishment of debt		-			583,326
Write off prepaid IPO costs		-			215,464
Changes in operating assets and liabilities:
Accounts receivable		20102,~~372~~198			(~~187~~161,~~933~~246	)
Inventories		~~131~~2,~~658~~937			(1179,~~088~~415	)
Prepaid expenses		6787,~~085~~843			(3537,~~659~~151	)
Other assets		(4124,~~782~~689	)		(619,~~304~~467	)
Accounts payable and accrued expenses		(538,046	)		923,616
Deferred costs		-			(39,751	)
Net cash used in operating activities		1,881,249	)		(2,104,150	)
Deferred revenue		-			45,000
Accounts payable and accrued expenses		(429,586	)		(640,951	)
Net cash used in operating activities		(3,011,705	)		(5,753,088	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment		-(60,701	)		(4163,~~216~~092	)
Net cash used in operating activities		-(60,701	)		(4163,~~216~~092	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from long term debt		1,966,768			2,355,636
Proceeds from long term debt, net of debt issue costs		3,197,948			6,564,356
Debt issue costs		(58,820	)		(188,516	)
Payments on long term debt		(21,379	)		(492,845	)
Payments on long term debt		(19,893	)		(88,439	)
Repurchase of common stock		-			(18	)
Net cash provided by financing activities		13,~~888~~176,~~055~~569			26,~~078~~071,~~681~~493
Net increase (decrease) in cash		6,806			(66,685	)
Net increase in cash		104,163			255,313
Cash beginning of period		26,250			75,536
Cash end of period	$	33130,~~056~~413		$	8330,~~851~~849
Supplemental disclosures of cash flow information:
Interest paid		-			~~212~~240,~~849~~244
Non-cash investing and financing activities:
Debt issuance costs related to issuance of warrants		-			147,879
Debt discount related to issuance of warrants		-			12,~~502~~448,753
Debt discount related to original issue discount on Hillair notes		~~235~~391,~~000~~800			-
Derivative obligation related to issuance of warrants		-			~~593~~1,539,559
Issuance of warrants in conjunction with issuance of promissory notes and amendments of promissory notes		-			1,057,073
Cancellation of shares subscribed		-			440,000
Exercise of Class B Warrants					170
Non-cash items related to acquisition
Patents		-			15,000
Goodwill		-			4,153,463
Assumption of liabilities		-			262,248
Fair value of preferred stock retained		-			1,650,000
Fair value of common retained		-			2,256,215

see accompanying notes to unaudited interim Condensed Consolidated Financial Statements

PFO GLOBAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

FOR THE THREE AND ~~SIX~~NINE MONTHS ENDED ~~JUNE~~SEPTEMBER 30, 2016 AND 2015

Note 1 - Summary of Significant Accounting Policies

Description of the Business

On June 30, 2015 (the “Effective Date”), Pro Fit Optix Holding Company, LLC (“Holding”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with PFO Global, Inc., formerly Energy Telecom, Inc. (the “Company”), and PFO Acquisition Corp., a wholly-owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on the Effective Date, the Company completed the acquisition of Holding by means of a merger of Merger Sub with and into Holding, such that Holding became a wholly-owned subsidiary of the Company (the “Merger”). Immediately following the Merger, the former PFO Global, Inc. equity holders owned approximately 8% of the outstanding shares of the Company’s common stock.

For accounting purposes, the Merger was recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 805-40, “Reverse Acquisitions.” Accordingly, PFO Global, Inc. has been recognized as the accounting acquiree in the Merger, with Holding being the accounting acquirer. As such, the historical financial statements of Holding will be treated as the historical financial statements of the combined company. Accordingly, the condensed consolidated balance sheets presented in the condensed consolidated financial statements reflect the financial position of the post-combination Company as of December 31, 2015 and the condensed consolidated statements of operations presented in the condensed consolidated financial statements reflect the operations of Holding for the period from January 1, 2015 through June 30, 2015, and the operations of the post-combination Company for the period of June 30, 2015 through December 31, 2015.

On the Effective Date, the Company had outstanding 23,.988 shares (the “Escrow Shares”) of Series A Convertible Preferred Stock (“Preferred Stock”). Pursuant to the Merger Agreement, on the Effective Date, the Preferred Stock was amended such that the Escrow Shares became convertible into an aggregate of 2,500,000 shares of common stock at the instruction of the holder. Further, the holder was required to assign the Preferred Stock to be held in escrow by an escrow agent (the “Escrow Agent”). On the Effective Date, Holding, Merger Sub, PFO Global, Inc., a third party (the “Account Advisor”) and the Escrow Agent entered into an Escrow Agreement (the “Escrow Agreement”), pursuant to which the Escrow Agent agreed to hold the Escrow Shares for release pursuant to written instructions provided from time to time by the Account Advisor. When the Escrow Agreement expires December 31, 2016, any Escrow Shares not released from escrow will be cancelled. As of ~~June~~September 30, 2016, no Escrow Shares had been released by the Escrow Agent.

PFO Global, Inc., formerly Energy Telecom, Inc., was incorporated in Florida on September 7, 1993 and reincorporated in Nevada on June 2, 2015 pursuant to an agreement and plan of merger between Energy Telecom, Inc. and its wholly owned subsidiary, Energy Telecom Reincorporation Sub, Inc., a Nevada corporation (“ET-NV”), whereby ~~our~~Holding ~~Company~~ merged with and into ET-NV with ET-NV as the surviving corporation that operates under the name “PFO Global, Inc.” Prior to the Merger, ~~our~~Holding’s mission was to monetize ~~our~~its global utility patent portfolio with claims covering certain features of intelligent eyewear.

The Company completed the Merger with Holding on June 30, 2015. Following the Merger, wethe Company began focusing its resources on the manufacturing and distribution of eyewear through proprietary manufacturing, ordering and delivery systems that reduce cost to eyewear providers, through Pro Fit Optix, Inc. (“Optix”), Holding’s wholly-owned subsidiary.

Optix, a Wyoming corporation, was incorporated on May 7, 2009. On February 9, 2011, Optix filed a voluntary petition for reorganization pursuant to a Chapter 11 Plan of Reorganization as entered in Optix’s bankruptcy in ~~case~~Case noNo. 11~13387 under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of Florida. On May 2, 2011, Optix filed a Plan of Reorganization (the “Optix Plan of Reorganization”) which was approved in August 2011. Pursuant to the Optix Plan of Reorganization, debtor-in-possession financing was provided by HCA DIP Capital Fund, LLC.

Holding, a Florida limited liability company, was formed on February 9, 2011. Holding was previously known as HCA DIP Capital Fund, LLC which was formed to provide and did provide debtor-in-possession financing as a lender to Optix. The members of HCA DIP Capital Fund, LLC were majority stockholders of Optix prior to its reorganization.

On May 17, 2012, Optix ~~successfully~~ emerged from bankruptcy and, in exchange for the outstanding debtor-in-possession financing, issued all of the outstanding shares of its new common stock to Holding and became a wholly owned subsidiary of Holding.

Three additional wholly-owned subsidiaries of Holding, PFO Technologies, LLC (“Tech”), PFO Optima, LLC (“Optima”), and PFO MCO, LLC (“MCO”), were incorporated on February 17, 2014, May 23, 2013 and July 5, 2013, respectively.

The Company manufactures and delivers complete eyewear, prescription lenses and related services to the managed care insurance industry, which services the Medicaid and Medicare entitlement programs, independent eye care providers and accountable care organizations. Optima distributes distortion free polycarbonate lenses under the Resolution® brand name. Tech’s focus is on the development of disruptive technologies for the eyewear industry and supports the research and development of other business units of the Company.

The developed products currently include:

●

SmartCalc - proprietary software used to manufacture fully digital lens designs. Certain Company lenses are produced following the SmartCalc software calculation.

●

SmartEyewear Online Ordering System - a business-to-business online ordering software system which allows eye care providers to quickly provide all necessary information for each patient’s eyewear package and unique use. It integrates the optical provider directly with the PFO worldwide lab system. The Company utilizes this system for all of its electronic ordering.

The Company is headquartered in Farmers Branch, Texas where primarily all corporate functions are performed as well as the support, sales and warehousing for all MCO and Tech products and services. ~~Optima has a facility in Stratford, Connecticut of which the primary function is to support the sales, administration and warehousing of the Optima products.~~ The Company utilizes a third party frame provider, Hong Kong Optical Lens Co. in Shenzhen, China (“HKO”) which sells frames to the Company and warehouses them in ~~their~~HKO’s facility until such time as the frames are released to designated laboratories to be fit with a lens. HKO is responsible to track and manage inventory on behalf of the Company from the point of purchase to the shipment of the frames to the laboratories.

All membership unit amounts have been restated to reflect the equivalent number of shares of common ~~shares~~stock to provide comparative information. All per share amounts are post Merger and post the stock split that occurred on July 6, 2015.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of PFO Global, Inc. and its wholly owned subsidiaries: Pro Fit Optix Holding Company, LLC, Pro Fit Optix, Inc., PFO MCO, LLC, PFO Optima, LLC and PFO Technologies, LLC, and have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and the rules and regulations of the Unites States Securities and Exchange Commission for interim financial information. The accompanying unaudited Condensed Consolidated financial statements should be read in conjunction with the Company’s audited financial statements and footnotes thereto for the fiscal year ended December 31, 2015.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The condensed consolidated financial statements reflect all adjustments (consisting primarily of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position and the results of operations. The operating results for the ~~six~~nine months ended ~~June~~September 30, 2016 are not necessarily indicative of the results to be expected for the full fiscal year 2016 or for any other interim period.

The December 31, 2015 condensed consolidated balance sheet has been derived from the audited financial statements as of that date, but does not include all disclosures required by GAAP. All membership unit amounts have been restated to reflect the equivalent number of shares of common stock to provide comparative information. All per share amounts are post merger amounts. Certain prior period amounts have been reclassified to conform to the current period presentation. All significant intercompany transactions and balances have been eliminated in consolidation.

Segment Information

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company and its Chief Executive Officer view the Company’s operations and manage its business as one operating segment. All revenues and long-lived assets of the Company are earned and reside in the United States.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates include the allowance for doubtful accounts, sales allowances, recoverability of long lived assets and goodwill, valuation allowance for deferred income tax assets, fair value of assets acquired and liabilities assumed, fair value of derivative liabilities and valuation of stock options and equity transactions. Actual results could differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

Cash and Cash Equivalents

For purposes of the consolidated statements of cash flows, the Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with financial institutions which balances may exceed the federally insured limits. Federally insured limits are $250,000 for interest and noninterest deposits. At ~~June~~September 30, 2016, the Company had no deposits in excess of federally insured limits.

Accounts Receivable

The Company does business and extends credit based on an evaluation of ~~the~~its customers’ financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company monitors exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The Company’s allowance for doubtful accounts was approximately $~~360~~248,~~000~~500 and $275,000 at ~~June~~September 30, 2016 and December 31, 2015, respectively.

Inventories

Inventory is comprised of finished goods frame and lens inventory at ~~June~~September 30, 2016 and December 31, 2015. In assessing the value of inventories, the Company makes estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the saleable condition of products and estimated prices at which those products will sell. On an ongoing basis, the Company reviews the carrying value of its inventory, measuring number of months on hand and other indications of salability. The Company reduces the value of inventory if there are indications that the carrying value is greater than market, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Inventories consist of finished product and are stated at the lower of cost, determined using the first-in first-out method, or market.

Debt Issue Costs

The Company amortizes debt issue costs to interest expense over the life of the associated debt instrument.

Shipping and Handling Costs

The Company charges customers for shipping and handling costs except for orders that are shipped directly to customers from the Company’s third party lens provider, HKO. Shipping and handling costs are classified as Revenues and Cost of Goods Sold in the Condensed Consolidated Statements of Operations.

Property and Equipment

Property and equipment are stated at cost. Depreciation on property and equipment is calculated on the straight-line basis over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter of the lease term or their estimated useful life. Maintenance and repairs are expensed as incurred; expenditures that enhance the value of property or extend the useful lives are capitalized. When assets are sold or returned, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is included in income.

The Company capitalizes certain website development costs incurred in designing, developing, testing and implementing enhancements to its website. These website development costs are amortized over the enhancement’s estimated useful life.

In addition to website development costs, capitalized software includes internally developed software to be sold, licensed or leased. The Company capitalizes internally developed software costs under the provisions of ~~Financial Accounting Standards Board (“~~FASB”) ~~Accounting Standards Codification (“~~ASC”) Topic 985, “Software,” which prescribes that capitalization of development costs of software products begins once the technological feasibility of the product is established. Capitalization ceases when such software is ready for general release, at which time amortization of the capitalized costs begins. Amortization of capitalized internally developed software is computed as the greater of: (a) the amount determined by the ratio of the product’s current revenue to its total expected future revenue or (b) the straight-line method over the product’s estimated useful life, generally three years. The Company has used the straight-line method to amortize such capitalized costs.

Impairment of Long-Lived Assets

The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future cash flows in accordance with accounting guidance. If circumstances suggest the recorded amounts cannot be recovered, based upon estimated future undiscounted cash flows, the carrying values of such assets are reduced to fair value. No impairment charges were recorded for long-lived assets for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015.

Income Taxes

The Company accounts for income taxes under the provisions of ~~Financial Accounting Standards Board (“~~FASB”) ~~Accounting Standards Codification (“~~ASC”) Topic 740, “Accounting for Income Taxes,” which requires that the Company recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements and tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The Company provides a valuation allowance against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized.

The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by taxing authorities, based on technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit and changes in facts or circumstances related to a tax position. Any changes to these estimates based on the actual results obtained and or a change in assumptions, could impact the Company’s tax provision in future periods. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for federal and state income taxes. The Company did not record any interest or penalties on uncertain tax positions in the accompanying condensed consolidated balance sheets and statements of operations for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively. Federal, state and local authorities may examine the Company’s income tax returns for three years from the date of filing. The December 31, 2015 tax returns and prior three years remain subject to examination as of ~~June~~September 30., 2016.

Loss Per Share

Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares and dilutive shares outstanding. As of ~~June~~September 30, 2016 and 2015 dilutive shares outstanding, whose impact was antidilutive, include options to purchase the Company’s common stock (“Options”) and warrants to purchase the Company’s common stock (“Warrants”). The dilutive impact of the Options and Warrants is determined by applying the “treasury stock” method.

The computation of the loss per share for the ~~six~~three and nine months ended ~~June~~September 30, 2016 and 2015, respectively, ~~and~~ excludes the following weighted average number of Options and Warrants because their inclusion would be anti-dilutive:

	June 30,2016		June 30,2015
	September 30,2016		September 30,2015
Options		2,~~859~~829,~~927~~875		75,130
Warrants		12,939,297		912,~~249~~049,297
Total		15,~~799~~769,~~224~~172		912,~~324~~124,427

Revenue Recognition

Revenue is derived from eyewear sales, technology sales, software revenue and term licensing revenue and is recorded in the period in which the goods are delivered or services are rendered and when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price to the customer is fixed or determinable, and collection is reasonably assured. The Company reduces revenue for estimated discounts, sales incentives, estimated customer returns, and other allowances and presents revenue, net of taxes collected from customers and remitted to governmental authorities.

Eyewear Sales

The Company recognizes product revenue upon shipment provided that there is persuasive evidence of an arrangement, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable, and collection of the resulting receivable is reasonably assured.

Technology Sales

Revenue and the related cost of sales on sales of the Company’s laser tracing system, eyeX³, are recognized when risk of loss and title passes, which is generally at the time of shipment. This product was discontinued in 2015 due to poor market demand.

Term Licensing Revenue

The Company applies the provisions of ASC Subtopic 985-605, “Software Revenue Recognition”, to all transactions involving the licensing of software products.

Term license revenue includes arrangements where the Company’s customers receive license rights to use its software along with bundled maintenance and support services for the term of the contract. The majority of the Company’s contracts provide customers with the right to use one or more products up to a specific license capacity. Certain of the Company’s license agreements stipulate that customers can exceed pre-determined base capacity levels, in which case additional fees are specified in the license agreement. Term license revenue is recognized ratably over the term of the license contract.

Deferred Revenue and Costs

On April 20, 2012, the Company sold software technology to VSP Labs, Inc. (“VSP”) pursuant to a Technology Transfer and Development Agreement (“TTDA”) (see Note 9). In accordance with the TTDA, the Company was required to perform additional production and customization of the software technology over the agreement term. The software technology required significant customization and development on the Effective Date and in accordance with ASC Subtopic 605-35, “Revenue Recognition” (“ASC 605-35”) the Company has accounted for the TTDA under the completed contract method. The Company and VSP are currently in litigation regarding the TTDA and the outcome is uncertain. Because of the uncertainties that exist under the contract, payments received and costs incurred under the TTDA have been deferred and will be recognized when the TTDA is considered complete and the litigation with VSP is settled.

In addition to the TTDA, the Company maintained a Purchase and Supply Agreement (“VSP Supply Agreement”) with VSP whereby the Company provided eyewear to VSP customers throughout California. In accordance with the VSP Supply Agreement, VSP was required to prepay for the orders of frame inventory. Payments received for prepaid orders are recorded in deferred revenue until such time inventory is shipped to VSP.

Equity-Based Compensation

Compensation expense for all stock-based employee and director compensation awards granted is based on the grant date fair value estimated in accordance with the provisions of ASC Topic 718, “Stock Compensation ~~(“ASC Topic 718~~”). The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award, which is generally the vesting term. Vesting terms vary based on the individual grant terms.

Advertising Costs

Advertising expenses are charged to expense as incurred. Advertising expense included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations amounted to approximately $39203,000 and $3792,000, for the ~~six~~nine month period ended ~~June~~September 30, 2016 and 2015, respectively. Advertising expense included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations amounted to approximately $30166,000 and $1955,000 for the three month period ended ~~June~~September 30, 2016 and 2015, respectively.

Derivative Financial Instruments

The Company reviews its financial instruments for the existence of embedded derivatives that may require bifurcation if certain criteria are met. These criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics of the host contract, (ii) the hybrid financial instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other applicable GAAP with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for which the host instrument is deemed conventional). A bifurcated derivative financial instrument is required to be recorded at fair value and adjusted to market at each reporting period end date.

Fair Value Measurements

In accordance with ASC 820, “Fair Value Measurements and Disclosures,” fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date.

The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:

●

Level 1: Quoted market prices in active markets for identical assets or liabilities.

●

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

●

Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

The carrying amounts of cash and cash equivalents, accounts receivables, and accounts payable and accrued expenses approximate their fair value due to their short-term nature or market terms. However, considerable judgment is involved in making fair value determinations and current estimates of fair value may differ significantly from the amounts presented herein. The fair value of the Company’s derivative obligation liability is classified as Level 3 within the fair value hierarchy because the valuation model of the derivative obligation is based on unobservable inputs.

Recently Issued Accounting Pronouncements

In May 2014, the ~~Financial Accounting Standards Board ("~~FASB") issued Accounting Standards Update (“ASU”) No. 2014-09, "Revenue from Contracts with Customers," ("ASU 2014-09") providing common revenue recognition guidance for ~~U.S.~~ GAAP. Under ASU 2014-09, an entity recognizes revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires additional detailed disclosures to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2017. The Company is currently evaluating the impact this standard will have on our condensed consolidated financial statements.

In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its financial position or results of operations.

In February 2015, the FASB issued ASU No. 2015-02 (“~~ASU 2015-02”), “~~Consolidation (Topic 810): Amendments to the Consolidation Analysis.” (“ASU 2015-02”). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company adopted this new standard as of January 1, 2016. The implementation of this standard did not have a material impact on the Company’s condensed consolidated financial statements and disclosures.

In July 2015, the FASB issued ASU No. 2015-11, "Simplifying the Measurement of Inventory" (“ASU 2015-11”) simplifying the measurement of inventory. The guidance requires an entity to measure inventory at the lower of cost or net realizable value, which consists of estimated selling prices in the ordinary course of business, less reasonably predictable cost of completion, disposal, and transportation. The new guidance eliminates unnecessary complexity that exists under current "lower of cost or market" guidance. For public entities, ASU No.2015-11 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The guidance is to be applied prospectively as of the beginning of an interim or annual reporting period, with early adoption permitted. The Company does not believe the implementation of this standard will have a material impact on its condensed consolidated financial statements and disclosures

In September 2015, the FASB issued ASU No. 2015-16, “Simplifying the Accounting for Measurement Period Adjustments” (“ASU 2015-16”) which requires that adjustments to provisional amounts identified during the measurement period of a business combination be recognized in the reporting period in which those adjustments are determined, including the effect on earnings, if any, calculated as if the accounting had been completed at the acquisition date. This eliminates the previous requirement to retrospectively account for such adjustments. ASU 2015-16 also requires additional disclosures related to the income statement effects of adjustments to provisional amounts identified during the measurement period. ASU 2015-16 became effective for public companies during interim and annual reporting periods beginning after December 15, 2015 with early adoption permitted. Accordingly, the Company adopted this new standard on January 1, 2016. The implementation of this standard did not have a material impact on the Company’s condensed consolidated financial statements and disclosures.

In November 2015, the FASB issued ASU No. 2015-17, `Balance Sheet Classification of Deferred Taxes" (“ASU 2015-17”) simplifying the balance sheet classification of deferred taxes. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. Under prior guidance, an entity was required to separate deferred income tax liabilities and assets into current and non-current amounts. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected. For public entities, the guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, with early adoption permitted. The guidance maybe applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The Company adopted the new guidance on a prospective basis for the fiscal year ended December 31, 2015. Financial statements for prior periods were not retrospectively adjusted. The new guidance had no impact on the Company's condensed consolidated financial statements.

In February 2016, the FASB issued new lease accounting guidance ASU No. 2016-02, “Leases” (“ASU 2016-02”). Under the new guidance, at the commencement date, lessees will be required to recognize a leases liability, which is a lessee’s obligation to make lease payments arising from a leases, measured on a discounted basis,; and a right-to-use asset, which is an asset that represented the lessee’s right to use, or control the use of, a specified asset for the lease term. The new guidance is not applicable for leases with a term of 12 months or less. Lessor accounting is largely unchanged. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) )” (“ASU 2016-09”). The update makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2016-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The Company is currently evaluating the effects of ASU 2016-09 on its financial statements.

In June 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230), a consensus of the FASB’s Emerging Issues Task Force.” The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including interim periods within those fiscal years. An entity that elects early adoption must adopt all of the amendments in the same period. The guidance requires application using a retrospective transition method. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on the Company’s consolidated cash flows.

Note 2 – Going Concern

As of ~~June~~September 30, 2016, the Company had cash of $33130,~~056~~413. As reflected in the accompanying condensed consolidated financial statements, the Company had a net loss of ~~approximately~~ $~~3.5~~4,735,782 ~~million~~ and net cash and cash equivalents used in operations of approximately $13.901 million for the ~~six~~nine month period ended ~~June~~September 30, 2016. The Company has a working capital deficit of approximately $~~17.1~~23 million and stockholders’ deficit of approximately $2829 million as of ~~June~~September 30, 2016. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

Historically, the Company has been dependent upon its ability to raise sufficient capital to continue its product and business development efforts. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital, increase its revenue and develop its technologies to the point of revenue recognition.

The Company’s primary source of operating funds since inception has been cash proceeds from issuance of notes payable. The Company intends to raise additional capital through private placements of debt and equity securities, but there can be no assurance that these funds will be available on terms acceptable to the Company, or will be sufficient to enable the Company to fully complete its development activities or sustain operations. The Company has raised approximately $13.92 million, net of repayments and debt issuance costs, in the ~~six~~nine month period ended ~~June~~September 30, 2016, through the issuance of ~~promissory~~convertible ~~notes~~debentures (see Note 5). Subsequent to September 30,2016 the Company has raised approximately $385,000 through the issuance of convertible debentures (see Note 13). However, there can be no assurance that the Company will be successful in raising additional funds.

Management believes that the actions presently being taken by the Company will provide sufficient liquidity for the Company to continue to execute its business plan. However, there can be no assurances that management’s plans will be achieved. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

Note 3 – Accounts Receivable

Accounts receivable consisted of the following as of:

	June 30, 2016			December 31, 2015
	September 30, 2016			December 31, 2015
Accounts receivable, trade	$	~~696~~610,~~767~~790		$	756,788
Other receivables		-			3,646
		696,767			760,434
		610,790			760,434
Less allowance for doubtful accounts		(~~360~~248,~~439~~468	)		(275,242	)
	$	~~336~~362,~~328~~322		$	485,192

Note 4 –Accrued Liabilities

Accrued liabilities consisted of the following as of:

	June 30 2016		December 31 2015
	September 30, 2016		December 31, 2015
Payroll and related taxes	$	~~216~~151,~~862~~920	$	641,622
Accrued interest, third parties		2,~~159~~829,~~952~~511		1,179,994
Accrued other		~~285~~563,~~842~~106		323,826
	$	23,~~662~~544,~~656~~537	$	2,145,442

Note 5– Notes Payable

Notes payable consisted of the following as of:

	June 30, 2016			December 31, 2015
	September 30, 2016			December 31, 2015
Notes payable	$	225,000		$	225,000
Convertible promissory note		200,000			200,000
Promissory note		50,000			50,000
Series A notes		3,002,500			3,002,500
Secured bridge notes		943,370			943,370
Convertible notes		2,045,000			2,045,000
Senior Secured Convertible Debentures		810,~~780~~236,~~000~~800			6,580,000
		15,245,870			13,045,870
		16,702,670			13,045,870
Less debt issuance costs		(~~521~~362,~~807~~206	)		(794,741	)
Less debt discounts		(1,~~631~~275,~~579~~344	)		(2,331,538	)
		13,092,484			9,919,591
		15,065,120			9,919,591
Less current maturities		(813,~~905~~532,~~000~~236	)		(6,705,000	)
Notes payable, less current maturities	$	41,~~187~~532,~~484~~884		$	3,214,591

The following table provides information regarding annual required repayments under the notes payable as of ~~June~~September 30, 2016:

2016	$	86,~~905~~705,000
2017		36,~~170~~827,~~436~~236
2018		3,170,434
	$	1516,~~245~~702,~~870~~670

Amortization of debt discount and debt issuance costs was approximately $~~634~~683,000 and $ 1683,~~026,~~000 for the three months ended ~~June~~September 30, 2016 and ~~June 30,~~ 2015, respectively, and $1,~~266~~949,000 and $23,~~233~~151,000 for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively.

Notes Payable

Convertible Promissory Note

On January 28, 2014, the Company entered into a convertible promissory note (“Convertible Note”) for a principal amount of $200,000 with a stated interest rate of 18%. On January 20, 2015 and April 2015 the maturity date of the Convertible Note was extended to June 30, 2015 and May 1, 2016, respectively. On June 29, 2015, the maturity date of the Convertible Note was further amended such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. All obligations under the Convertible ~~Promissory~~ Note were secured by a first priority security interest in all inventory of Optima. In conjunction with the Convertible Note, the Company issued a five year warrant to purchase 57,820 shares of common stock (approximately 0.4% of the Company's then total issued and outstanding shares of common stock) for an exercise price of $1.00 per share.

Because of the variable nature of the embedded warrants, the Convertible Note has been accounted for in accordance with ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The fair value of the warrants issued with the Convertible Note (as determined using the Black Scholes valuation model) was determined to be nominal, and therefore, no derivative liability or offsetting debt discount was included in the Company's condensed consolidated balance sheet as of ~~June~~September 30, 2016 and December 31, 2015. Management ~~will~~is ~~continue~~continuing to measure the fair value of this instrument each reporting period through maturity date and record the impact under ASC 815 should the value become meaningful to the Company's consolidated condensed financial statements.

Promissory Note

On February 12, 2014, the Company entered into a promissory note (“Promissory Note”) for a principal amount of $50,000 with a stated interest rate of 18%. In April 2015, the maturity date of the ~~Convertible~~Promissory Note was amended to May 1, 2016. On June 29, 2015, the maturity date of the ~~Convertible~~Promissory Note was further amended such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.

Series A Private Placement

On various dates from May 1, 2014 through September 19, 2014, the Company issued and sold 299.25 investment units to accredited investors (the “Series A Private Placement”). Each investment unit was sold at a purchase price of $10,000 and consisted of (i) a Series A secured promissory note in the principal amount of $10,000 (collectively the “Series A ~~Note~~Notes”), (ii) a five-year Class A warrant to purchase 6,250 shares of common stock at an exercise price of $1.60 per share, exercisable in whole or in part as of the date of issuance (collectively the “Class A Warrants”), and (iii) five-year Class B warrants to purchase 1,756.6 shares of common stock at an exercise price of $0.01 per share, exercisable in whole or in part as of the date of issuance(collectively the “Class B Warrants”). Proceeds received from the Series A Private Placement were approximately $2,633,000 net of related costs of approximately $360,000.

In January 2015, the Company amended certain of the Series A Notes. Note holders representing $2,255,000 of outstanding principal amount of Series A Notes entered into amendments whereby (a) each Series A Note matures on the earlier of (i) the 12-month anniversary of the issuance date and (ii) the completion of any merger with or acquisition by a third party; and (b) upon an initial public offering or cash acquisition of the Company, the outstanding principal and interest will automatically convert into Common Stock at a per share conversion price equal to (i) in the event of an initial public offering, 100% of the offering price of the Common Stock in the Public Offering or (ii) in the event of an acquisition, 80% of the per share valuation of the Company’s equity in connection with the acquisition.

In conjunction with the amendments, the Company issued five year Class A Warrants to purchase an aggregate of 1,039,063 shares of common stock to note holders and 83,125 shares of common stock to the private placement agent at an exercise price of $1.60 per share, exercisable in whole or in part as of the date of issuance. The fair value of the Class A Warrants was included in derivative liabilities on the Company’s condensed consolidated balance sheet at the issuance date and re-measured at each reporting period.

Also, in May 2015, the Company amended certain of the Series A Notes whereby each Series A Note matures on the earlier of: (i) the 24-month anniversary of the issuance date; (ii) the completion of any acquisition, merger or consolidation of the Company in which the collective ownership of the Company in the transaction would own, in the aggregate, a lower percentage of the total combined voting power of the surviving entity than the acquiring company’s collective ownership; (iii) thirty (30) days following the funding of any financing that results in a listing of the Company’s common stock on a national exchange (i.e., the Nasdaq or NYSE); or (iv) the sale by the Company of all or substantially all the Company’s assets in one transaction or in a series of related transactions.

The Company accounted for the borrowing under the Series A Notes, the Class A Warrants and the Class B Warrants in accordance with the guidance prescribed in ASC Subtopic 470-20, `“Debt with Conversion and other Options.” (“ASC 470-20”).In accordance with ASC 470-20, the fair value of the Class A Warrants and the relative fair value of the Class B Warrants are considered an original issue discount which is required to be amortized over the life of the note as interest expense using the effective interest rate method.

In conjunction with the amendments, the Company issued (i) five year Class A Warrants to purchase an aggregate of 1,876,563 shares of common stock to note holders and approximately 149,625 shares of common stock to the private placement agent and (i) five year Class B Warrants to purchase an aggregate of 527,421 shares of common stock to note holders and approximately 42,053 shares of common stock to the private placement agent. The fair value of the Class A Warrants was included in derivative liability on the Company's condensed consolidated balance sheet at the issuance date and re-measured at each reporting period (see Note 8). The fair value of the Class B Warrants was included in stockholders’ deficit in the Company's condensed consolidated balance sheet at ~~June~~September 30, 2016.

In June 2015, the Company amended the maturity date of each Series A Note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendments were accounted for as modifications of debt. In conjunction with the amendments, the Company issued five year Class A Warrants to purchase an aggregate of 150,125 shares of common stock to the private placement agent. The fair value of the Class A Warrants was included in derivative liability on the Company's condensed consolidated balance sheet and re-measured at each reporting period (see Note 8).

Secured Bridge Private Placement

On various dates from September 19, 2014 through November 18, 2014, the Company issued and sold 115.5 investment units to accredited investors (the “Secured Bridge Private Placement”). Each investment unit was sold at a purchase price of $10,000 and consisted of (i) a secured promissory note in the principal amount of $10,000 (the “Bridge Note”), (ii) five-year Class A Warrant to purchase 6,250 shares of common stock, and (iii) five-year Class B Warrant to purchase 1,756.6 shares of common stock. The Class A Warrants and Class B Warrants had exercise prices of $1.60 and $.01 per share, respectively.

In May 2015, the Bridge Notes were amended, modifying the maturity date of the Bridge Notes such that each Bridge Note matures on the earlier of: (i) the receipt of funds from accounts receivable in the aggregate principal amount then outstanding of all Bridge Notes; (ii) the receipt of gross proceeds from any accounts receivable financing or factoring financing in an amount equal to at least the aggregate Bridge Note principal; (iii) thirty (30) days following the funding of any financing that results in a listing of the Company’s common stock on a national exchange; (iv) the sale by the Company of all or substantially all the Company’s assets in one transaction or in a series of related transactions; (v) the completion of any acquisition, merger or consolidation of the Company in which the collective ownership of the Company in the transaction would own, in the aggregate, a lower percentage of the total combined voting power of the surviving entity than the acquiring company’s collective ownership; and (vi) January 1, 2016.

The Company accounted for the borrowing under the Secured Bridge Notes, the Class A Warrants and the Class B Warrants in accordance with the guidance prescribed in ASC 470-20~~, `Debt with Conversion and other Options~~.” In accordance with ASC 470-20, the fair value of the Class A Warrants and the relative fair value of the Class B Warrants are considered an original issue discount which is required to be amortized over the life of the note as interest expense using the effective interest rate method.

In conjunction with the amendments, the Company issued (i) five year Class A Warrants to purchase an aggregate of 721,875 shares of common stock to note holders and approximately 57,750 shares of common stock to the private placement agent and (ii) five year Class B Warrants to purchase an aggregate of 202,888 shares of common stock to note holders and approximately 16,231 shares of common stock to the private placement agent. The fair value of the Class A Warrants was included in derivative liability on the issuance date and re-measured at each reporting period (see Note 8). The fair value of the Class B Warrants was included in stockholders’ deficit on the issuance date.

In June 2015, the Company further amended the maturity date of certain Bridge Notes such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. In July 2015, a Bridge Note with an original principal amount of $125,000 was repaid. In conjunction with the amendments, the Company issued five year Class A Warrants to purchase an aggregate of 643,750 shares of common stock to note holders and approximately 57,750 shares of common stock to the private placement agent. The fair value of the Class A Warrants was included in derivative liability at the issuance date and re-measured as of the reporting period.

Convertible Notes Private Placement

On various dates from January 1, 2015 through June 30, 2015, the Company issued and sold 179.5 investment units to accredited investors (the “Convertible Notes Private Placement”). Each investment unit was sold at a purchase price of $10,000 and consisted of (i) a convertible promissory note in the principal amount of $10,000 (collectively, the “Convertible Notes”) and (ii) a five year Class C warrant to purchase 1,502.6 shares of common stock, ~~exercisable in whole or in part as of the date of issuance~~ (collectively, the “Class C Warrants”). As a result of the Convertible Notes Private Placement, the Company issued warrants to purchase an aggregate of 269,717 shares of common stock. In connection with the Convertible Note Private Placement, the Company issued to the placement agent (i) five-year Class C Warrants to purchase an aggregate of 21,577 shares of common stock.

Each Convertible Note bears interest at a rate of 9% per annum and matures on the 12-month anniversary of the issuance date unless converted into equity upon an initial public offering of the Company’s securities or a cash acquisition of the Company. The terms of the Convertible Notes provide that the unpaid principal and interest amounts will automatically convert into common stock in the event of an initial public offering or an acquisition at a per share conversion price equal to (i) in the event of an initial public offering, eighty percent (80%) of the offering price of the Common Stock in the Public Offering or (ii) in the event of an acquisition, 80% of the per share valuation of the Company’s equity in connection with the acquisition.

The terms of the Class C Warrants provide that the exercise price of each warrant shall be (i) if the warrant ~~becomes~~is ~~exercisable~~exercised on the Company’s initial public offering date, 110% of the per warrant share offering price of the Company’s securities in its initial public offering, (ii) if the warrant is exercised upon the occurrence of an acquisition of the Company, the lower of (x) 20% discount to the warrant share valuation in the acquisition and (y) a per warrant share price based on a fully diluted market capitalization value of one hundred million dollars ($100,000,000) on the date of the acquisition, and (iii) if the warrant is exercised on June 30, 2015, a per warrant share price based on a fully diluted market capitalization value of one hundred million dollars ($100,000,000) on June 30, 2015. At the time of issuance, the Company determined that the variable exercise price feature on the Class C Warrants constituted a derivative liability because the variable exercise price feature represents a variable conversion feature.

The Company accounted for the borrowing under the Convertible Notes and the Class C Warrants in accordance with the guidance prescribed in ASC 470-20~~, “Debt with Conversion and other Options~~.” In accordance with ASC 470-20, the fair value of the Class C Warrants is considered an original issue discount which is required to be amortized over the life of the note as interest expense using the effective interest rate method.

The fair value of the Class C Warrants was immaterial on the issuance dates and ~~June~~September 30, 2016 (see Note 8). The Company used a Binomial Lattice Valuation Model to calculate the fair value of the Class C Warrants.

Proceeds received from the Convertible Note Private Placement were approximately $1,565,000, net of related costs of approximately $230,000.

In June 2015, the Company amended the maturity date of each Convertible Note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018, unless earlier converted into equity.

In conjunction with the amendments, the Company issued five year Class A Warrants to purchase an aggregate of 102,250 shares of common stock to the private placement agent. The fair value of the Class A Warrants was included in derivative liability at the issuance date and re-measured as of the reporting period (see Note 8).

Short-Term Promissory Note

In May 2015, the Company entered into a promissory note (“Short-Term Promissory Note”) for a principal amount of $100,000 with a stated interest rate of 9%.

In June 2015, the Company amended the maturity date of the Short-Term Promissory Note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018, unless earlier converted into equity. Such amendment was accounted for as a modification of debt.

In conjunction with the Short-Term Promissory Note, the Company issued (i) five year Class A Warrants to purchase an aggregate of 62,500 common shares at an exercise price of $1.60 per share and (i) five year Class B Warrants to purchase an aggregate of 17,566 common shares at an exercise price of $0.01 per share. In conjunction with the amendment, in June 2015, the Company issued five year Class A ~~Warrants~~Warrant to purchase an aggregate of 62,500 common shares to the note holder and approximately 5,000 common shares to the private placement agent.

The terms of the Class A Warrants provide that, in the event the Company receives gross proceeds of at least $1,000,000 in a qualified financing (as defined therein) at a per share price of less than $1.60 per share, the exercise price will reset to 80% of the financing price. At the time of issuance, the Company determined that the price protection feature on the Class A Warrants constituted a derivative liability because the price protection feature represents a variable conversion feature.

The Company accounted for the borrowing under the Short-Term Promissory Note, the Class A Warrants and the Class B Warrants in accordance with the guidance prescribed in ASC 470-20, ~~“Debt with Conversion and other Options.”~~ In accordance with ASC 470-20, the fair value of the Class A Warrants and the relative fair value of the Class B Warrants are considered an original issue discount which is required to be amortized over the life of the note as interest expense using the effective interest rate method.

The relative fair value of the Class B Warrants was recorded in stockholders’ deficit on the issuance date. The Company used the Black-Scholes pricing model to calculate the fair value of the Class B Warrants.

The Company used a Binomial Lattice Valuation Model to calculate the fair value of the Class A Warrants on the issuance date and is re-measured at each reporting period (see Note 8).

Promissory Note

In June 2015, the Company entered into a promissory note for a principal amount of $400,000 with the Royalty Obligation Purchaser (see Note 6). $275,000 of principal was repaid, as well as a $50,000 interest payment, in July 2015; and the remaining $125,000 principal amount was due on July 1, 2016.

The Company was unable to make the July 1, 2016 principal payment. Based on the Company’s current financial condition, there can be no certainty that the Company will be able to make the payment and is currently negotiating with the Royalty Obligation purchaser for an extension of the maturity date.

Securities Purchase Agreements

On various dates from June 30, 2015 through ~~December~~September 3130, ~~2015~~2016, the Company entered into a series of securities purchase agreements (each, a “Securities Purchase ~~Agreements~~Agreement” (and collectively, the “~~2015~~ Securities Purchase Agreements”) with Hillair Capital Investment L.P. (the “Investor”), pursuant to which the Company sold ana ~~aggregate~~series of ~~$6,580,000 in principal amount of an 8%~~ original issue discount senior secured convertible ~~debenture,~~debentures ~~dated July 1~~(each, ~~2015~~a ~~(the~~ “Debenture”), ~~for~~and ~~an aggregate purchase price of $6~~collectively,~~145,000~~ to the ~~Investor. Pursuant to the Securities Purchase Agreement, the Company also issued to the Investor warrants, (the~~ “~~SPA Warrant~~Debentures”)~~, to purchase an aggregate of 3,290,000 shares of our common stock (subject to adjustment)~~. The Debenture matures on January 1, 2017, and accrues interest at the rate of 8% per annum. One quarter of the original principal amount of the Debenture is payable on each of July 1, 2016 and October 1, 2016, and the remaining principal amount of the Debenture is payable on January 1, 2017. 8% Accrued interest on the Debenture is payable on January 1, April 1, July 1 and October 1 of each year, commencing on April 1, 2016.

Pursuant to the Securities Purchase Agreements dated June 30, 2015 through December 31, 2015, the Company sold an aggregate of $6,580,000 in principal amount of Debentures dated July 1, 2015, to the Investor for an aggregate purchase price of $5,875,000. Pursuant to the Securities Purchase Agreements dated June 30, 2015 through December 31, 2015, the Company also issued warrants to the Investor to purchase an aggregate of 3,290,000 shares of the Company’s common stock (subject to adjustment) (collectively, the “Investor Warrants”). The Debentures sold in 2015 mature on January 1, 2017, and accrue interest at the rate of 8% per annum. One quarter of the original principal amount of the Debentures sold in 2015 is payable on each of July 1, 2016 and October 1, 2016, and the remaining principal amount of the Debentures sold in 2015 is payable on January 1, 2017. 8% accrued interest on the Debentures sold in 2015 is payable on January 1, April 1, July 1 and October 1 of each year, commencing on April 1, 2016.

The Company did not make its April 1, 2016 ~~and~~or July 1, 2016 interest payments ~~under~~or the ~~Debenture~~July ~~and~~1, ~~the~~2016 principal payment due onunder the Debentures sold in 2015. On July 18, 2016., ~~The~~the Company ~~has~~ received a waiver from the Investor extending ~~the~~any scheduled interest and principal payments to January 1, 2017. Based on the Company’s current financial condition, there can be no certainty that the Company will be able to make the delinquent interest and principal payments and accordingly the outstanding principal amount due under the ~~Debenture~~Debentures sold in 2015 has been presented as current in the Company’s condensed consolidated balance sheets.

On January 7, 2016 the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $504,000 in principal amount of a Debenture for an aggregate purchase price of $450,000 to the Investor. ~~The~~This Debenture matures on February 1, 2017, and ~~accrues~~does not bear interest atbut ~~the~~has an effective interest rate of 812% per annum. ~~No warrants were granted related to these issuances in 2016.~~

On February 17, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $616,000 in principal amount of a Debenture for an aggregate purchase price of $550,000 to the Investor. ~~The~~This Debenture matures on March 1, 2017, and ~~accrues~~does not bear interest atbut ~~the~~has an effective interest rate of 812% per annum. ~~No warrants were granted related to these issuances in 2016.~~

On April 14, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $828,~~000~~800 in principal amount of a Debenture for an aggregate purchase price of $740,000 to the Investor. ~~The~~This Debenture matures on May 1, 2017, and ~~accrues~~does not bear interest atbut ~~the~~has an effective interest rate of 812% per annum. After taking into account legal and diligence fees of $27,500 reimbursed to the Purchaser, the net proceeds received by the Company was $712,500. No warrants were granted related to these issuances in 2016.

On June 13, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $252,000 in principal amount of a Debenture for an aggregate purchase price of $225,000 to the Investor. ~~The~~This Debenture matures on July 1, 2017, and ~~accrues~~does not bear interest atbut ~~the~~has an effective interest rate of 812% per annum~~. No warrants were granted related to these issuances in 2016.~~

~~Proceeds~~On ~~received~~July ~~from~~8, 2016, the ~~Debentures~~Company ~~were~~entered ~~approximately~~into ~~$1,906,000,~~an ~~net~~additional ofSecurities ~~related~~Purchase ~~costs~~Agreement ofwith ~~approximately~~the ~~$59~~Investor,~~000~~ ~~and~~pursuant ~~original~~to ~~issue~~which ~~discounts~~the Company sold an aggregate of $~~235~~616,000 ~~respectively,~~in ~~during~~principal ~~the~~amount ~~six~~of ~~months~~a ~~ended~~Debenture ~~June~~for 30an aggregate purchase price of $550,000 ~~2016~~to the Investor. ~~Debt~~This ~~issuance~~Debenture ~~costs~~matures ~~will~~on beJuly ~~amortized~~1, to2017, and does not bear interest ~~expense~~but ~~over~~has ~~the~~an ~~life~~effective interest rate of ~~the~~12% ~~Debentures~~per annum.

~~Amounts~~On ofAugust ~~principal~~16, ~~and~~2016, ~~accrued interest under~~ the ~~Debenture~~Company ~~are~~entered ~~convertible at the option of the Investor at any time~~ into ~~shares of our common stock at~~ an ~~initial~~additional ~~conversion~~Securities ~~price~~Purchase ~~(as~~Agreement ~~may~~with ~~be adjusted,~~ the ~~“Conversion Price”) of $2.00 per share~~Investor, ~~subject~~pursuant to ~~certain~~which ~~ownership limitations and adjustment provisions. The Conversion Price is subject to reduction to an amount equal to 90% of~~ the ~~effective price per share of securities issued by the~~ Company ~~(i)~~sold inan aaggregate ~~registered offering~~ of our common stock or securities convertible into or exchangeable for shares of our common stock (collectively “Common Stock Equivalents”) or (ii) in any other financing or series of financings of our common stock or Common Stock Equivalents with gross proceeds of $4448,000~~,000~~ orin more (each, a “Triggering Event”). Beginning six months after the original issue date for each Debenture, the Company has the option, subject to certain conditions, to redeem some or all of the then outstanding principal amount of ~~the~~a Debenture for ~~cash in~~ an ~~amount~~aggregate ~~equal~~purchase toprice ~~the sum~~ of ~~(i)~~$400,000 ~~120%~~to of the ~~then~~Investor. ~~outstanding~~The ~~principal~~Debenture ~~amount~~matures ofon ~~such~~August ~~Debenture~~1, ~~(ii)~~2017, ~~accrued but unpaid interest~~ and ~~(iii)~~does ~~any~~not ~~liquidated~~bear ~~damages~~interest ~~and~~but ~~other~~has ~~amounts~~an ~~due~~effective ininterest ~~respect~~rate of ~~such~~12% ~~Debenture~~per annum.

On September 15, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $392,000 in principal amount of a Debenture for an aggregate purchase price of $350,000 to the Investor. The Debenture matures on September 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum.

Proceeds received from the Debentures sold in 2016 were approximately $3,198,000, net of related costs of approximately $69,000 and original issue discounts of $392,000 respectively, during the nine months ended September 30, 2016. Debt issuance costs will be amortized to interest expense over the life of the Debentures sold in 2016. No warrants were issued in connection with the Debentures issued in 2016.

Principal and accrued interest amounts under the Debentures are convertible at the option of the Investor at any time into shares of the Company’s common stock at an initial conversion price (as may be adjusted, the “Conversion Price”) of $2.00 per share, subject to certain ownership limitations and adjustment provisions. The Conversion Price is subject to reduction to an amount equal to 90% of the effective price per share of securities issued by the Company (i) in a registered offering of our common stock or securities convertible into or exchangeable for shares of the Company’s common stock (collectively “Common Stock Equivalents”) or (ii) in any other financing or series of financings of the Company’s common stock or Common Stock Equivalents with gross proceeds of $4,000,000 or more (each, a “Triggering Event”). Beginning six months after the original issue date for each Debenture, the Company has the option, subject to certain conditions, to redeem some or all of the then outstanding principal amount of the Debenture for cash in an amount equal to the sum of (i) 120% of the then outstanding principal amount of such Debenture, (ii) accrued but unpaid interest and (iii) any liquidated damages and other amounts due in respect of such Debenture.

Pursuant to the terms of the ~~Debenture~~Debentures, the Company has agreed to certain negative covenants, including not to incur or repay any other indebtedness, for so long as any portion of the Debenture remains outstanding.

Each of the ~~SPA Warrants (collectively, the “~~Investor Warrants”) is exercisable for a period of five years from the original issue date of each Investor Warrant, at an initial exercise price of $2.40 per share (the “Investor Warrant Exercise Price”) ~~of $2~~.40 ~~per share.~~ In addition to customary adjustments for stock splits and the like, if a Triggering Event occurs, the Investor Warrant Exercise Price is subject to reduction to the Conversion Price applicable as a result of such Triggering Event, in which event the number of shares of common stock issuable under the Investor Warrants would be increased such that the aggregate Investor Warrant Exercise Price payable under the Investor Warrants, after taking into account the decrease in the Investor Warrant Exercise Price, would be equal to the aggregate Investor Warrant Exercise Price prior to such adjustment. If at any time after the six month anniversary of the original issue date for each Investor Warrant there is no effective registration statement registering, or no current prospectus available for, the resale of the shares of common stock underlying the Investor Warrant, then such Investor Warrant may be exercised, in whole or in part, at such time on a “cashless exercise” basis.

The Company’s obligations under the Debentures are secured by a lien on all of the Company’s assets, including a pledge of the securities of its subsidiaries, pursuant to the terms of a security agreement entered into as of June 30, 2015 between the Company and the Investor.

Pursuant to the terms of the ~~2015~~ Securities Purchase Agreements dated June 30, 2015 through December 31, 2015, the Investor received a right of first refusal to purchase up to 100% of the securities offered by the Company in future private placement offerings through November 30, 2016. In addition, from the original issue date for each Debenture and Investor Warrant until the 12-month anniversary of the date the Company’s common stock is listed on Nasdaq or NYSE MKT, the Investor may, in its sole determination, elect to purchase, in one or more purchases, additional debentures with an aggregate subscription amount of up to $4,000,000, and Investor Warrants to purchase that number of shares of the Company’s common stock equal to the original principal amount of such additional debentures divided by $2.00. Subject to certain exceptions, the Company agreed (i) for a period of 180 days following the closing date for each Securities Purchase Agreement , not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of common stock or any securities convertible into or exchangeable for shares of common stock, and (ii) until such time as the Debentures and Investor Warrants are no longer outstanding, not to issue any shares of common stock or any securities convertible into or exchangeable for shares of common stock at an effective per share purchase price of less than $2.40 (subject to adjustment for stock splits and the like), provided that after the time that the related Debentures are no longer outstanding, the Company may receive a waiver from such restriction by paying the Investor an amount in cash equal to 15% of the purchase price paid by the Investor for the related Debentures. If at any time during the period beginning on the six-month anniversary of the closing date for each Securities Purchase Agreement and ending at such time as all of the shares of common stock underlying the related Debentures and Investor Warrants can be sold without restriction or limitation pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, if the Company either (i) shall fail for any reason to satisfy the current public information requirements contained in Rule 144 or (ii) shall have ever been, or become, an issuer described in section (i)(1)(i) of Rule 144, then the Company shall be obligated to pay to the Investor an amount in cash, as liquidated damages and not as a penalty, equal to 2% of the purchase price paid by the Investor for the Debenture per month until the applicable event giving right to such payments is cured (or the Investor is nonetheless able to transfer the Securities pursuant to Rule 144).

On the Effective Date, pursuant to the terms of the Securities Purchase Agreement dated as of the Effective Date, the Investor entered into a lock-up agreement (the “Investor Lock-Up Agreement”), pursuant to which it agreed, subject to certain exceptions and conditions, not to sell any of the Securities for a period commencing on the Effective Date and ending on the earlier of (i) the first anniversary of the Effective Date, (ii) the date on which the Company notifies the Investor of its intention to redeem some or all of the outstanding principal amount of the Debenture pursuant to the terms thereof or (iii) a trading day on or after the nine-month anniversary of the Effective Date on which either: (x) the aggregate dollar trading volume of the Company’s common stock since the Effective Date equals or exceeds $10,000,000 (provided that since the Effective Date, the closing bid price of the Company’s common stock has been equal to or exceeded $4.00 for a period of 30 consecutive trading days) or (y) the closing bid price of the Company’s common stock equals or exceeds $8.00 for a period of 30 consecutive trading days.

At the time of issuance, the Company determined that (i) the net share settlement (cashless exercise) provision on the Investor Warrants and (ii) the variable Debenture conversion price constituted derivative liabilities because the variable exercise price and variable Debenture conversion price features represented variable conversion features.

The Company accounted for the borrowing under the Debentures, the Investor Warrants and the conversion rights in accordance with the guidance prescribed in ASC 470-20~~, “Debt with Conversion and other Options~~.” In accordance with ASC 470-20, the fair value of the Investor Warrants and the conversion rights are considered original issue discounts, required to be amortized over the life of the note as interest expense using the effective interest rate method.

The fair value of the Investor Warrants and conversion rights were recorded on the issuance dates using a Binomial Lattice Valuation Model, which was included in derivative liability on the Company’s condensed consolidated balance sheets, and re-measured as of September 30, 2016 (see Note 8).

The fair value of the SPA Warrants and conversion rights were recorded on the issuance dates using a Binomial Lattice Valuation Model, which was included in derivative liability on our consolidated balance sheets, and re-measured as of June 30, 2016 (see Note 8).

Note 6 – Royalty Obligation

~~The~~On June 25, 2014, the Company entered into a ~~Royalty~~royalty ~~Purchase~~purchase ~~Agreement~~agreement (the “Royalty Obligation”) with a third party (“Purchaser”) as amended in May and June 2015. Under the terms of the amended Royalty ~~Purchase Agreement~~Obligation, the Company was advanced $1,750,000 by the Purchaser and in return, the Company agreed to pay the Purchaser a royalty amount equal to 3.09% of monthly revenue generated from products or services that incorporate any of the Company's intellectual property ("IP Revenue") including patents, copyrights and trademarks in perpetuity ("Royalty Payments"). No monthly Royalty Payments for any calendar month will be less than $36,458.

The monthly royalty payments were deferred from April 2015 through June 2016 and were due on July 1, 2016.

The Company did not make the July 1, 2016 royalty payment under its Royalty Obligation. The Company is negotiating an extension to the due date. Based on the Company’s current financial condition, there can be no certainty that the Company will be successful in such negotiations or that the Company will be able to make the delinquent royalty payments and accordingly the outstanding royalty amount due under the Royalty Obligation has been presented as current in the Company’s condensed consolidated balance sheets.

Royalty expense of approximately $109,000 and $93120,000 is included in Interest Expense, other on the Company’s condensed consolidated statement of operations for the three months ended ~~June~~September 30, 2016 and 2015, respectively.

Royalty expense of approximately $~~218~~328,000 and $~~187~~307,000 is included in Interest Expense, other on the Company’s condensed consolidated statement of operations for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively.

Approximately $~~559~~698,000 and $~~290~~370,000 of accrued royalty expense was included in accounts payable and accrued liabilities on the Company’s condensed consolidated balance sheets as of ~~June~~September 30, 2016 and December 31, 2015, respectively. As of ~~June~~September 30, 2016 and December 31, 2015, $1,750,000 was outstanding under the Royalty Obligation.

Note 7 – Related Party Transactions

Long-term notes due to related parties consist of the following:

	June 30, 2016		December 31, 2015
	September 30, 2016		December 31, 2015
The Company has a unsecured note payable with HP Equity Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrue at 4.5% per annum.	$	1,030,639	$	1,030,639
The Company has an unsecured note payable with HP Equity Fund LLC pursuant to the Optix Plan of Reorganization. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrue at 4.5% per annum.	$	1,030,639	$	1,030,639
The Company has a note payable with HCA Capital Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note payable is secured by substantially all of the assets of the Company. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrues at 9.5% per annum.		448,993		448,993
The Company has a note payable with HCA Capital Fund LLC pursuant to the Optix Plan of Reorganization. The note payable is secured by substantially all of the assets of the Company. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrues at 9.5% per annum.		448,993		448,993
The Company has a unsecured note payable with PFO Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrues at 4.5% per annum.		206,565		206,565
The Company has an unsecured note payable with PFO Fund LLC pursuant to the Optix Plan of Reorganization. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrues at 4.5% per annum.		206,565		206,565
The Company has a promissory note with Transition Capital, LLC dated September 1, 2012, as amended. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrue at 5.5% per annum		1,550,200		1,550,200
The Company has an unsecured promissory note with Atlas Technologies, AG which is owned by a relative of the Company’s former Chief Executive Officer (“CEO”) dated December 30, 2012 at a stated annual interest rate of 5.5%. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		117,700		117,700

	June 30, 2016			December 31, 2015
	September 30, 2016			December 31, 2015
The Company has an agreement with its former CEO effective February 2011 to pay an automobile allowance of $1,633 per month through the date of termination. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. The note was settled pursuant to the termination agreement as disclosed below.		-			52,108
The Company has an agreement with its former CEO effective February 2011 to pay an automobile allowance of $1,633 per month through the date of termination. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. The note was settled pursuant to the consulting agreement entered into with the Company’s former CEO, as disclosed below.		-			52,108
The Company has a promissory note with a relative its former CEO effective September 6, 2011 at a stated annual interest rate of 0%. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		47,210			47,210
The Company has three promissory notes with three stockholders dated July 2011 at a stated annual interest rate of 9.5%. In June 2015, the Company amended the maturity date of the July 2011 notes such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		1,134,~~214~~215			1,134,215
The Company has four promissory notes with four stockholders dated May 2015 at a stated annual interest rate of 4.5%. In June 2015, the Company amended the maturity date of the July 2011 notes such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		90,000			90,000
Total long term notes to related parties		4,625,~~521~~522			4,677,630
Less current maturities		-(2,312,761	)		-
Total long term notes to related parties, net of current maturities	$	42,~~625~~312,~~521~~761		$	4,677,630

The following table provides information regarding annual required repayments under the notes payable, as amended, as of ~~June~~September 30, 2016:

2016	$	-
2017		2,312,761
2018		2,312,~~760~~761
	$	4,625,~~521~~522

The Company incurred interest expense of approximately $73,000 and $75,000 for the three months ended ~~June~~September 30, 2016 and 2015, and interest ~~expenses~~expense of approximately $~~151~~224,000 and $~~149~~224,000 for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively, which is presented in interest expense – related parties in the accompanying condensed consolidated statements of operations. As of ~~June~~September 30, 2016 and December 31, 2015, approximately $1,~~339~~414,000 and $1,188,000 of accrued but unpaid interest is presented in accrued interest, related parties in the accompanying condensed consolidated balance sheets, respectively.

Approximately $240,000 was due to the chairman of the Company’s board of directors, a related party, as of ~~June~~September 30, 2016 and December 31, 2015, respectively for consulting fees.

The Company paid PFO Europe, a company owned by a relative of the Company’s former CEO, approximately $0 and $3264,000 in fees and expenses during the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively, to market the Company’s products and services in Europe.

The Company ~~did~~paid ~~not make any payments to~~ PFO Europe, aapproximately ~~company~~$0 ~~owned~~and ~~by a relative of the Company’s former CEO~~$32,000 in fees and expenses during the three months ended ~~June~~September 30, 2016 and 2015, respectively.

On February 29, 2016, Rudolf Suter retired from his position as Chief Executive Officer of the Company. The Company entered into a consulting agreement with Mr. Suter pursuant to which Mr. Suter ~~will~~provided ~~provide~~ certain advisory services in exchange for 3% of net sales that he ~~generates~~generated. Such commissions ~~will~~were be paid in the form of options. In addition, Mr. Suter was paid $65,000 in cash and granted 400,000 options, at a weighted averaged exercise price of $.30 per share, under the 2015 Stock Option Plan with an estimated fair value of $28,000 (see Note 11) in full and final settlement of deferred salary and accrued vacation of approximately $152,000 and outstanding principal and interest due to Mr. Suter under his ~~existing~~ automobile allowance of approximately $60,000. The Company also reclassified its security deposit under its existing PFO Europe lease to expense as these services are no longer provided upon Mr. Suter’s departure. The consulting agreement was terminated on May 26, 2016. All remaining principal and interest due to Mr. Suter or relatives of Mr. Suter under existing notes payable agreements and previous option grants to Mr. Suter remain outstanding under existing terms as of ~~June~~September 30, 2016.

Note 8- Derivative Obligation

Class A Warrants

As of ~~June~~September 30, 2016, 58,~~011~~183,~~750~~446 Class A Warrants were issued and outstanding. The Company did not grant any Class A Warrants during the ~~six~~nine months ended ~~June~~September 30, 2016. The Company determined that the price protection feature on the Class A Warrants constituted a derivative liability because the price protection feature represents a variable conversion feature, and estimated the fair value of the derivative liability of approximately $~~795,000~~0 using a Binomial Lattice Valuation Model and the following assumptions as of ~~June~~September 30, 2016:

Present Value of Share		$0.130008
Expected Volatility	~~101~~84.4147%	-	~~107~~99.7371%
Expected Term (in years)	2.966	-	43.074
Discount Rate	0.7087%	-	01.8601%
Dividend Rate		0%
Exercise Price		$0.070005

Expected volatilities are based on the historical volatilities of comparable companies, industry indexes, and other factors. Expected term is based on remaining term of the Class A Warrants. The discount rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term. The present value of a share is based upon management’s estimate of the equity value of the Company and the number of shares outstanding.

The Company recorded a gain of approximately $81795,~~600~~000 during the three months ended ~~June~~September 30, 2016 and a loss of approximately $~~810~~280,000 during the three months ended ~~June~~September 30, 2015, representing the net change in the fair value of the derivative liability for such periods, which are presented as fair value changes of derivative instruments, net in the accompanying condensed consolidated statements of operations.

The Company recorded a gain of approximately $~~240~~1,~~600~~036,000 during the ~~six~~nine months ended ~~June~~September 30, 2016 and a loss of approximately $33313,000 during the ~~six~~nine months ended ~~June~~September 30, 2015, representing the net change in the fair value of the derivative liability for such periods, which are presented as fair value changes of derivative instruments, net in the accompanying condensed consolidated statements of operations.

In accordance with GAAP, the following table represents the Company’s fair value hierarchy for its Class A Warrants measured at fair value on a recurring basis as of ~~June~~September 30, 2016:

Balance at 6/30/2016

Level 1

Level 2

Level 3

Balance at 9/30/2016

Level 1

Level 2

Level 3

Derivative Obligation

~~795,391~~0

The following table reflects the change in fair value of the Company’s Class A Warrants for the period ended ~~June~~September 30, 2016:

	Amount
Balance – January 1, 2016	$	1,036,000
Addition of derivative obligation at fair value on date of issuance		-
Change in fair value of derivative obligation		(~~240~~1,~~609~~036,000	)
Balance – June 30, 2016	$	795,391
Balance – September 30, 2016	$	0

Class C Warrants

As of ~~June~~September 30, 2016, ~~291~~331,~~294~~861, Class C Warrants were issued and outstanding. The Company did not grant any Class C Warrants during the ~~six~~nine months ended ~~June~~September 30, 2016.

The Company determined that the price protection feature on the Class C Warrants constituted a derivative liability because the variable exercise price represents a variable conversion feature.

As of ~~June~~September 30, 2016, the Company determined that the fair value of the derivative liability pertaining to the Class C Warrants was immaterial as of such date. The fair value of the derivative obligation was estimated using Binomial Lattice Valuation Model and the following assumptions:

Present Value of Share		$0.130008
Expected Volatility	~~101~~95.3426%	-	~~103~~96.7758%
Expected Term (in years)	3.525	-	43.074
Discount Rate	0.7291%	-	0.8797%
Dividend Rate		0%
Exercise Price		$2.20

Expected volatilities are based on the historical volatilities of comparable companies, industry indexes, and other factors. Expected term is based on remaining term of the Class C Warrants. The discount rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term. The present value of a share is based upon management’s estimate of the equity value of the Company and the number of shares outstanding.

The fair value of the derivative liability related to the Class C Warrants did not change materially from the date of issuance to ~~June~~September 30, 2016.

~~SPA~~Investor Warrants

As of December 31, 2015, 3,290,000 ~~SPA~~Investor ~~warrants~~Warrants were issued and outstanding. The Company did not grant any ~~SPA~~Investor Warrants during the 6nine months ended ~~June~~September 30, 2016. The Company determined that the net settlement (cashless exercise) feature on the ~~SPA~~Investor Warrants constituted a derivative liability because the net settlement feature represents a variable conversion feature. As of ~~June~~September 30, 2016 the Company estimated the fair value of the derivative liability of approximately $~~329,000~~0 using a Binomial Lattice Valuation Model and the following assumptions:

Present Value of Share		$0.130008
Expected Volatility	9894.7623%	-	~~101~~94.4184%
Expected Term (in years)	43.75	-	4.4116
Discount Rate	01.8601%	-	01.9208%
Dividend Rate		0%
Exercise Price	~~$0.07~~	-$0.0005	~~$0.08~~

Expected volatilities are based on the historical volatilities of comparable companies, industry indexes, and other factors. Expected term is based on remaining term of the ~~SPA~~Investor Warrants. The discount rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term. The present value of a share is based upon management’s estimate of the equity value of the Company and the number of shares outstanding.

The Company recorded a gain of approximately $27329,000 and a loss of $0134,000 during the three months ended ~~June~~September 30, 2016 and 2015, respectively, representing the net change in the fair value of the derivative liability for such periods, which are presented as fair value changes of derivative instruments, net in the accompanying condensed consolidated statements of operations.

The Company recorded a gain of approximately $98427,000 and a loss of $0134,000 during the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively, representing the net change in the fair value of the derivative liability for such periods, which are presented as fair value changes of derivative instruments, net in the accompanying condensed consolidated statements of operations.

In accordance with GAAP, the following table represents the Company’s fair value hierarchy for ~~its~~the ~~SPA~~Investor Warrants measured at fair value on a recurring basis as of ~~June~~September 30, 2016:

Balance at 6/30/2016

Level 1

Level 2

Level 3

Balance at 9/30/2016

Level 1

Level 2

Level 3

Derivative Obligation

~~329,000~~0

The following table reflects the change in fair value of the Company’s derivative liabilities for the period ended ~~June~~September 30, 2016:

	Amount
Balance – January 1, 2016	$	427,~~500~~000
Addition of derivative obligation at fair value on date of issuance		-
Change in fair value of derivative obligation		(98427,~~500~~000	)
Balance – June 30, 2016	$	329,000
Balance – September 30, 2016	$	0

Debenture Conversion Feature

The Debentures issued during the year ended December 31, 2015 (see Note 5) and the ~~six~~nine months ended ~~June~~September 30, 2016, include a conversion feature whereby they can be converted into 3,290,000 and 1,~~056~~828,~~000~~400 shares of common ~~shares~~stock, subject to certain adjustments. At the time of issuance, the Company determined that the variable nature of the conversion feature constituted a derivative liability. During the ~~six~~nine months ended ~~June~~September 30, 2016, the Company estimated the fair value of the derivative liability of approximately $0 using a Binomial Lattice Valuation Model and the following assumptions:

Present Value of Share		$0.130008
Expected Volatility	5949.757%	-	6858.2552%
Expected Term (in years)	0.525	-	1.96
Discount Rate	0.3629%	-	0.4558%
Dividend Rate		0%
Exercise Price		$2.00

Expected volatilities are based on the historical volatilities of comparable companies, industry indexes, and other factors. Expected term is based on the expected remaining term of the conversion feature. The discount rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term. The present value of a share is based upon management’s estimate of the equity value of the Company and the number of shares outstanding.

The Company recorded a gain/(loss) of approximately $0 and $041,000 during the three months ended ~~June~~September 30, 2016 and 2015 and a gain/(loss) of approximately $306,000 and $041,000 during the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively, representing the net change in the fair value of the derivative liability for such periods, which are presented as fair value changes of derivative instruments, net in the accompanying condensed consolidated statements of operations.

In accordance with GAAP,, the following table represents the Company’s fair value hierarchy for its debenture conversion feature measured at fair value on a recurring basis as of ~~June~~September 30, 2016:

Balance at June 30, 2016

Level 1

Level 2

Level 3

Balance at September 30, 2016

Level 1

Level 2

Level 3

Derivative Obligation

The following table reflects the change in fair value of the Company’s Debenture Conversion Feature for the period ended ~~June~~September 30, 2016:

	Amount
Balance – January 1, 2016	$	306,000
Addition of derivative obligation at fair value on date of issuance		-
Change in fair value of derivative obligation		(306,000	)
Balance – June 30, 2016	$	-
Balance – September 30, 2016	$	-

The following table reflects the fair value of the Company’s derivative liabilities as of ~~June~~September 30, 2016:

	Amount
Class A Warrants	$	~~795,391~~0
SPA Warrants		329,000
Investor Warrants		0
Debenture Conversion Feature		-
	$	~~1,124,391~~0

Note 9 - Commitment and Contingencies

Operating Lease Agreements

During 2015, the Company leased 4,500 square feet at 7501 Esters Boulevard, Suite 100, Irving, Texas 75063 at approximately $11,300 per month. The lease expired on June 30, 2016. On March 8, 2016, the Company moved its corporate office to 14401 W. Beltwood Parkway, Farmers Branch, TX 75244.

In conjunction with the Company’s acquisition of Optima in March 2013, the Company assumed a facility lease with an unrelated third party at 111 Research Drive, Stratford, CT 06615. The office space at this location consisted of approximately 10,200 square feet and cost the Company approximately $8,513 per month. The lease expired on May 31, 2016.

The Company consolidated facilities into a new location at 14401 W. Beltwood Parkway, Farmers Branch, TX 75244 and completed the consolidation in May 2016. The Company believes that its facilities are suitable and adequate to meet its current business requirements. The current office space at this location consists of approximately 15,500 square feet and costs the Company approximately $10,400 per month. The lease is set to expire on February 29, 2019.

Approximate annual future minimum lease payments under all operating leases, as amended, subsequent to ~~June~~September 30, 2016 are as follows:

2016	$	4929,000
2017		~~113~~104,000
2018		132,000
2019		2211,000
Total minimum lease payments	$	~~316~~276,000

Rental expense for the three months ended ~~June~~September 30, 2016 and 2015 was approximately $6029,000 and $8781,000 and ~~six~~nine months ended ~~June~~September 30, 2016 and 2015 was approximately $~~130~~159,000 and $~~155~~236,000 respectively.

Litigation

From time to time, the Company is subject to lawsuits and claims that arise out of its operations in the normal course of business. The Company is a plaintiff or a defendant in various litigation matters in the ordinary course of business, some of which involve claims for damages that are substantial in amount. The Company believes that the disposition of any claims that arise out of operations in the normal course of business will not have a material adverse effect on the Company’s financial position or results of operations.

VSP Labs, Inc.

On April 20, 2012, Pro Fit Optix, Inc. (“Optix”) sold software technology to VSP Labs, Inc. (“VSP”) pursuant to a Technology Transfer and Development Agreement (“TTDA”) for $6,000,000 payable in bi-annual installments of $1,000,000 through October 15, 2014 net of credits and incentives as defined in the TTDA. In accordance with the TTDA, Optix was required to perform additional production and customization of the software technology over the agreement term. The software technology required significant customization and development on the effective date and in accordance with ASC 605-35, the Company has accounted for the TTDA under the completed contract method.

On October 25, 2013, VSP filed a lawsuit against Optix in the Superior Court of California, County of Sacramento – Unlimited Civil Division. The lawsuit alleges, among other things, that Optix has failed to provide certain services under the TTDA between the parties which allegedly triggered the right of VSP to perform such services on its own or to engage third parties to render such services. The lawsuit seeks declaratory relief to establish that VSP was entitled to perform the services that the Company allegedly failed to perform and also seeks to establish that VSP is entitled to deduct the fees and expenses associated with the performance of such services from the payments that VSP is otherwise required to make under the terms of the TTDA, in addition to recovery of attorneys’ fees and costs associated with the lawsuit. On December 23, 2014, the Company filed a cross complaint against VSP seeking damages based on breach of contract and unfair business practices. On June 17, 2015 the Company and VSP participated in a mediation to resolve the case. AThe trial date of October 31, 2016 has been ~~set~~continued by the court to March 13, 2017. The Company plans to vigorously protest VSP’s claim and continue to pursue the uncollected portions under the TTDA as well as damages under its cross complaint. The Company is unable to express an opinion as to the likely outcome of this claim. An unfavorable outcome could have a materially adverse effect on the Company’s financial position and results of operations.

Deferred revenue, which is comprised of payments received under the TTDA and prepaid orders of frame inventories were approximately $2,582,000 as of ~~June~~each of September 30, 2016 and December 31, 2015. Deferred costs, comprised of costs incurred related to the TTDA, were approximately $294,000 as of ~~June~~each of September 30, 2016 and December 31, 2015.

Claim Investment Agreement

On March 4, 2016, ~~Pro Fit~~ Optix, ~~Inc., a subsidiary of the Company,~~ and Hillair Capital Management LLC (“Hillair”) entered into a claim investment agreement (the “Claim Investment Agreement”). Pursuant to the Claim Investment Agreement, Optix may from time to time submit to Hillair directions to pay, or fund in advance, the legal fees and expenses of Optix’s attorney of record in that certain lawsuit captioned VSP Labs, Inc. v. Pro Fit Optix, Inc., pending in the Sacramento Superior Court, Sacramento County, California, Action No. 34-2013-00153788 (the “Lawsuit”), to which Optix is a party, and Hillair will cause Hillair Capital Investment L.P. (“HCI”) to pay such legal fees and expenses on Optix’s behalf. Each payment made pursuant to the Claims Investment Agreement shall constitute an “Investment”, and the sum of all Investments made shall be referred to as the “Investment Amount”.

The Claim Investment Agreement contains customary representations, warranties and covenants of Optix and Hillair, and each party agreed to keep confidential and not use or disclose the confidential information of the other party.

In consideration for the Investment, if a final disposition or settlement of any claim in connection with the Lawsuit (“Claims”) results in a Recovery (as defined in the Claim Investment Agreement) to Optix, Optix shall first pay to HCI 100% of any Recovery until HCI has received an amount equal to the Investment Amount, and second, 50% of the amount of any Recovery in excess of the Investment Amount (collectively, the “Hillair Return”). In the event payment is not made to HCI in accordance with the Claims Investment Agreement, Optix shall pay to HCI interest of 24% per annum on any unpaid balances until paid in full.

The Investment is being made on a non-recourse basis to Optix; however, Pro Fit Optix has granted to HCI a security interest in the amount of the Hillair Return against Optix’s portion of any Recovery. In addition, the non-recourse limitation shall not apply at any time an Event of Default (as defined in the Claims Investment Agreement) exists or has occurred and is continuing.

If for any reason Hillair does not fulfill its obligation to cause HCI to pay legal fees or expenses, Optix’s sole and exclusive remedy is termination of the Claim Investment Agreement. No termination of the Claims Investment Agreement shall relieve Optix of its obligations thereunder until the Hillair Return has been fully and finally discharged and paid. In addition, pursuant to the Claims Investment Agreement, Hillair has the right, in its sole and absolute discretion, to cease and revoke its funding obligations in the event of any unfavorable procedural or substantive outcome occurred in furtherance of the Claims, including but not limited to motions, petitions, verdicts, judgments, orders or appeals granted against Optix.

Optix granted Hillair an exclusive right of first refusal for any additional funding that Optix may desire in connection with the Claims. In addition, Optix agreed to limit all advances, including those already taken against the Claims, to a total of $250,000, and Optix may not receive funding in excess of such amount from any source other than HCI without Hillair’s express written consent. Hillair has continued to fund legal fees in excess of $250,000.

~~The~~Since ~~Claim~~March ~~Investment Agreement contains customary representations~~4, ~~warranties~~2016 ~~and~~through ~~covenants~~the end of ~~Optix~~September ~~and~~30, ~~Hillair~~2016, ~~and~~HCI ~~each~~has ~~party~~incurred ~~agreed~~approximately to$354,000 ~~keep~~in ~~confidential~~legal ~~and~~fees ~~not~~on ~~use or disclose~~ the ~~confidential information of the other party~~lawsuit.

Since March 4, 2016 through the end of June 30, 2016, HCI has incurred approximately $167,000 in legal fees on the lawsuit.

Waud Capital Partners, L.L.C.

On May 22, 2014, Waud Capital Partners, L.L.C. (“Waud”) filed a breach of contract suit against Optix in the Circuit Court of Cook County, Illinois. In its complaint, Waud alleges that pursuant to the terms of the letter agreement between the parties, it is entitled to reimbursement of certain expenses in the amount of approximately $111,000 that Waud incurred in connection with its proposed investment in Optix, in addition to recovery of attorneys’ fees and costs associated with the lawsuit. In May 2015, the lawsuit was settled for $120,000 to be paid via twelve monthly payments beginning June 1, 2015, and such cost, net of payments, is included in accounts payable and accrued liabilities on the Company’s condensed consolidated balance sheets as of ~~June~~September 30, 2016 and December 31, 2015, respectively. As of ~~June~~September 30, 2016, the outstanding balance was $70,000. The Company is currently in default under this agreement and Waud has instituted legal proceedings to obtain a ~~judgement~~judgment.

Denton-Harvest

Rudolf Suter, the Company’s former Chief Executive Officer, is the defendant in a civil action in the United States District Court for the Northern District of Texas, Dallas Division. The plaintiffs, Peter Denton and Harvest Investors, L.P., since January 27, 2012, have filed garnishments related to payments from Pro Fit Optix, Inc. to Mr. Suter on several occasions. The plaintiffs have also alleged fraudulent conveyances of funds from Mr. Suter to his wife through a “conspiracy” with us. Plaintiffs seek approximately $676,000 plus costs from us, Mr. Suter and his wife.

~~The~~All ~~Company~~litigation ~~plans~~brought toby ~~protest~~Peter ~~the~~Denton ~~plaintiffs’~~and ~~claims.~~Harvest ~~The~~Investors, ~~Company~~L.P. isagainst ~~unable to express an opinion as to~~ the ~~likely~~Company, ~~outcome of this claim. A trial date of June 5~~Holdings, ~~2017~~and Optix has been ~~set~~dismissed bywith ~~the court~~prejudice.

HKO Purchase and Supply Agreement

On August 31, 2010, the Company entered into a Purchase and Supply Agreement with HKO (“HKO Supply Agreement”) with headquarters in Shenzhen, China.

In accordance with the HKO Supply Agreement, HKO sells eyewear, which consists of frames and lenses, and provides frame inventory management services to the Company. The Company provides frames to HKO to fulfill future orders of eyewear and maintains title and risk of loss to these frames while the frames reside in HKO’s warehouse in accordance with the HKO Supply Agreement. Once the frames are used by HKO to fulfill orders of eyewear, risk of loss transfers until such time the eyewear is received by the Company at its facility in Texas or a designated third party which is typically within 2-3 days of order fulfillment. As of ~~June~~September 30, 2016 and December 31, 2015, approximately $~~177~~196,000 and $208,000, respectively, of inventory pertains to frame inventory maintained in HKO’s warehouse for frames that have not yet been used to fulfill orders of eyewear.

The Company and HKO have the option to terminate the HKO Supply Agreement if either of the following occurs (i) the other party breaches any material provision of the agreement and the breaching party fails to cure such material breach within thirty days following written notice; or (ii) the other party becomes the subject of any voluntary or involuntary proceeding under the applicable national, federal, or state bankruptcy or insolvency laws and such proceeding is not terminated within sixty (60) days of its commencement. Any change in the Company’s relationship with HKO, could have an adverse effect on the Company’s business.

Purchases from HKO represented approximately 6246% ($~~780~~851,000) and 4961% ($~~513~~933,000) of the Company’s total purchases for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015, respectively. As of ~~June~~September 30, 2016 and December 31, 2015, approximately $~~304~~172,000 and $357,000, respectively, was due to HKO which is presented in accounts payable in the accompanying condensed consolidated balance sheets.

2930

Note 10 – Customer and Vendor Concentrations

During the three month periods ended ~~June~~September 30, 2016 and 2015, there were ~~was~~ one and ~~customer~~four customers who accounted for approximately 1323% and 2561% of the Company’s net sales, respectively. During the ~~six~~nine month periods ended ~~June~~September 30, 2016 and 2015, there was one customer who accounted for approximately 2118% and 1314% of the Company’s net sales, respectively. Approximately $~~146~~177,000 and $186,000 which accounts for approximately 3029% and 25% of accounts receivable, trade was due from these customers as of ~~June~~September 30, 2016 and December 31, 2015, respectively.

The main materials used in the Company’s products are polycarbonate and plastic. The Company has many suppliers and sources for these materials to meet their purchasing needs at prices which would not significantly impair their ability to compete effectively. During the ~~three~~nine month periods ended ~~June~~September 30, 2016 and 2015, there were three suppliers which accounted for approximately 8684% and 7993% of the Company’s net purchases, respectively. ~~During the six month periods ended June 30, 2016 and 2015, there were three suppliers which accounted for approximately 91% and 81% of the Company’s net purchases, respectively.~~ Approximately $~~476~~242,000 and $450,000 which accounts for approximately 2112% and 19% of accounts payable was due to the Company’s major vendors as of ~~June~~September 30, 2016 and December 31, 2015, respectively.

Note 11 – EQUITY COMPENSATION PLAN

OPTIONS GRANTED

During the 6nine months ended ~~June~~September 30, 2016, the Company granted 1,045,875 and 400,000 options to its current and former CEO, respectively, at a weighted averaged exercise price of $.30 per share. The options granted to the Company’s current CEO vest over a 5 year period and expire 10 years from the grant date. The options granted to the Company’s former CEO vested immediately and expire 4.5 years from the grant date pursuant to a consulting agreement with Mr. Suter (see Note 7). The weighted average grant date fair value was $.07 per share using the following assumptions:

Stock price	$.13	-	$.14
Expected Volatility	99%	-	119.15%
Expected Term (in years)	4.5	-	6.5
Discount Rate	.935%	-	1.17%
Dividend Rate		0%

The following table summarizes the ~~Option~~option activity for the ~~six~~nine months ended ~~June~~September 30, 2016:

	Number ofOptions			Weighted Average Exercise Price		Weighted AverageRemainingContractualLife (in Years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2015		1,444,104		$	0.46		5.03	$	—
Granted		1,445,875		$	0.30		—8.6		—
Exercised		—			—		—		—
Expired or forfeited or cancelled		(3060,~~052~~104	)		3.33		6.94		—
Outstanding as of June 30, 2016		2,859,927		$	.33		6.53	$	—
Outstanding as of September 30, 2016		2,829,875		$	.30		6.29	$	—
Exercisable at June 30, 2016		1,814,052		$	.35		4.53	$	—
Exercisable at September 30, 2016		1,784,000		$	.30		4.25	$	—

The following table summarizes the Company’s option activity for non-vested options for the ~~six~~nine months ended ~~June~~September 30, 2016:

	Number ofOptions			Weighted AverageGrant Date Fair Value
Nonvested as of December 31, 2015		305,833		$	0.11
Granted		1,445,875			.07
Vested		(705,833	)		.09
Expired or forfeited or cancelled		—			—
Nonvested as of June 30, 2016		1,045,875		$	.07
Nonvested as of September 30, 2016		1,045,875		$	.07

Stock based compensation was approximately $6872,000 and $0 for the 6nine months ended ~~June~~September 30, 2016 and 2015, respectively. Stock based compensation was approximately $493,~~000~~700 and $0 for the 3three months ended ~~June~~September 30, 2016 and 2015, respectively. Total equity based compensation related to non-vested awards not yet recognized as of ~~June~~September 30, 2016 and ~~June~~September 30, 2015 was approximately $6561,000 and $0, respectively.

3031

Note 12– Stockholders’ Equity / Deficit

Warrants

The Company did not grant any warrants during the ~~six~~nine month period ended ~~June~~September 30, 2016. The following summarizes the Company’s warrant activity for the ~~six~~nine months ended ~~June~~September 30, 2016:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)
Outstanding as of January 1, 2015		12,939,297	$	1.73		4.23
Outstanding as of January 1, 2016		12,939,297	$	1.73		4.23
Granted		-		-		-
Exercised		-		-		-
Canceled/Forfeited		-		-		-
Outstanding as of June 30, 2016		12,939,297	$	1.73		3.73
Outstanding as of September 30, 2016		12,939,297	$	1.73		3.48
Exercisable as of June 30, 2016		11,863,127	$	1.89		3.85
Exercisable as of September 30, 2016		11,863,127	$	1.89		3.59

As of ~~June~~September 30, 2016, warrants to purchase approximately 1,076,000 ~~remain~~shares of common stock remained unvested. The fair value of the warrants will be expensed based on vesting or probable vesting of such warrants. The following summarizes the Company’s outstanding warrants as of ~~June~~September 30, 2016:

	Number of Warrants
Class A Warrants		8,183,446
Class C Warrants		331,861
SPA Warrants		3,290,000
Investor Warrants		3,290,000
Other Warrants		1,133,990
Outstanding as of June 30, 2016		12,939,297
Outstanding as of September 30, 2016		12,939,297

Note 13– Subsequent Events

On ~~July~~October 810, 2016, Brigitte Rousseau, the former chief financial officer of the Company, entered into ana ~~additional~~consulting ~~Securities~~agreement ~~Purchase~~with the Company (the “Consulting Agreement”). ~~with~~Pursuant to the ~~Investor~~Consulting Agreement, ~~pursuant~~Ms. Rousseau agreed to ~~which~~provide certain advisory services to the Company, ~~sold~~as andirected ~~aggregate~~by the Company’s board of ~~$616~~directors,~~000~~ infor ~~principal~~up ~~amount~~to oftwenty ahours ~~Debenture~~per week for ana ~~aggregate~~period ~~purchase~~of ~~price~~six months. The Company agreed to pay to Ms. Rousseau (i) a monthly fee in the amount of $~~550~~12,~~000~~330 and (ii) for any hours worked by Ms. Rousseau pursuant to the ~~Investor~~Consulting Agreement that exceed eighty hours in any calendar month, an additional fee of $100 per hour. The ~~Debenture~~term ~~matures~~of the Consulting Agreement commenced on ~~July~~September 1, ~~2017,~~2016 and ~~accrues~~continues ~~interest~~until atFebruary 28, 2017, subject to the ~~rate~~early oftermination 8%provisions ~~per~~provided ~~annum.~~in the Consulting Agreement.

On ~~July~~October 817, 2016, the Company entered into aan ~~letter~~additional ~~agreement~~Securities ~~with~~Purchase ~~the Investor (the “Letter~~ Agreement~~”),~~ ~~whereby~~with the Investor, aspursuant ~~holder~~to ofwhich the ~~2015~~Company ~~Debentures,~~sold ~~agreed~~an toaggregate ~~extend~~of ~~to January 1~~$431,200 ~~2017~~in ~~the~~principal ~~Company’s~~amount ~~requirement under each~~ of ~~the~~a ~~2015~~Debenture ~~Debentures~~ to ~~pay interest to~~ the Investor onfor ~~April~~an ~~1, 2016 (previously extended to June 30, 2016) and July 1, 2016 on the~~ aggregate ~~unconverted~~purchase ~~and~~price ~~then outstanding principal amount~~ of ~~the 2015 Debentures~~$385,000. atThis ~~the~~Debenture ~~rate~~matures ofon 8%October ~~per annum, to waive late fees with respect to such interest until January~~ 1, 2017, and todoes ~~extend~~not ~~the~~bear ~~July~~interest 1,but ~~2016~~has ~~and~~an ~~October~~effective 1,interest ~~2016~~rate ~~periodic~~12% ~~redemption~~per ~~dates until January 1, 2017~~annum. ~~Except~~No aswarrants ~~specifically~~were ~~set~~issued ~~forth~~ in ~~the~~connection ~~Letter~~with ~~Agreement,~~this ~~all~~Debenture ~~of the terms and conditions of the 2015 Debentures are and will remain in full force and effect~~issuance.

On August 16, 2016, the Company entered into an additional securities purchase agreement with the Investor, pursuant to which the Company sold an aggregate of $448,000 in principal amount of a debenture to the Investor for an aggregate purchase price of $400,000 (the “August Debenture”). The August Debenture matures on August 1, 2017, and accrues interest at the rate of 8% per annum. No warrants were granted related to this issuance.32

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information set forth below should be read in conjunction with our condensed consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Unless otherwise stated, references in this Quarterly Report on Form 10-Q to “us,” “we,” “our,” or our “Company” refer to PFO Global, Inc. and its subsidiaries.

Forward-Looking Statements

This Quarterly Report on Form 10-Q (including the section entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations) contains “forward-looking statements” regarding our business, financial condition, results of operations and prospects. All statements other than statements of historical fact contained herein, including statements regarding our business plans or strategies, projected or anticipated benefits or other consequences of our plans or strategies, projected or anticipated benefits from acquisitions to be made by us, or projections involving anticipated revenues, earnings or other aspects of our operating results, are forward-looking statements. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “assume,” “can,” “could,” “forecast,” “guide,” “may,” “project,” “target,” “would” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this Quarterly Report on Form 10-Q. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to:

● our history of recurring losses and negative cash flows, significant future commitments and the uncertainty regarding the adequacy of our liquidity to pursue our business objectives;

● our ability to execute our business plan, fund our operations and continue as a going concern;

● our failure to maintain proper and effective internal controls;

● our significant amount of indebtedness and increased need for additional financing;

● our dependence on a limited number of suppliers;

● intense competition in our industry, including large, well-established companies; and

● those factors set forth under “Risk Factors” in Part II, Item 1.A of our Quarterly Report on Form 10-Q for the period ended March 31, 2016, as well as those discussed elsewhere in this Quarterly Report on Form 10-Q.

Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report on Form 10-Q. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this Quarterly Report on Form 10-Q, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Overview

We are an innovative manufacturer and commercial provider of advanced prescription lenses, finished eyewear and vision technologies targeted towards the global optometrists’ marketplace. Our ~~uniquely~~ interactive manufacturing, fulfillment and proprietary online ordering systems ~~combine~~combined with our eyewear lens product lines, are intended to meet the needs of a broad array of eyewear markets, from the offices of independent eye care professional to U.S. healthcare entitlement programs, such as Medicaid and Medicare.

Headquartered in Farmers Branch, Texas, we provide eyewear and prescription lenses to eye care professionals and prescription laboratories. We have developed proprietary cloud based software and electronic devices to streamline logistics and reduce costs for our customers. Additionally, we offer a high-resolution polycarbonate lens that we believe has lower distortion than competing lenses. We believe that the ~~combination~~offering of our high quality lenses at low price points combined with our proprietary software and electronic devices enable independent eye care professionals to compete more effectively with large retail chains in the eyewear industry. Further, ~~we believe that~~ our low price points enable us to participate in the United States Medicaid and Medicare programs, as well as insurance programs mandated by the Patient Protection and Affordable Care Act which requires pediatric vision coverage.

We have incurred losses from inception and have an accumulated deficit of $3738.35 million as of ~~June~~September 30, 2016. Until we are able to generate revenues that result in positive margins from the sale of eyewear and prescription lenses that exceed operating costs, profitable operations will not be attained and we will have to continue funding future cash needs through financing activities. In the event that we choose or need to raise additional capital, we may be required to do so in such a manner that will result in further dilution of an investor’s ownership and voting interest. Also, any new securities may have rights, preferences or privileges senior to those of our current common stockholders. Furthermore, sales of substantial amounts of our common stock in the public market could have an adverse effect upon the market price of our common stock and make it more difficult for us to sell equity securities in the future and at prices we deem appropriate.

The market price of our common stock is volatile because we have a very small public float and a limited trading market. Future announcements concerning our major customers or competitors, the results of product testing, technological innovations or commercial products, government rules and regulations, developments concerning proprietary rights, and litigation may have a significant impact on the market price of the shares of our common stock.

3233

Summary of Recent Developments

Completion of Merger

On June 30, 2015 (the “Effective Date”), Pro Fit Optix Holding Company, LLC (“Holding”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Company, formerly Energy Telecom, Inc. and PFO Acquisition Corp., a wholly-owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on the Effective Date, the Company completed the acquisition of Holding by means of a merger of Merger Sub with and into Holding, such that Holding became a wholly-owned subsidiary of the Company (the “Merger”). Immediately following the Merger, the former PFO Global, Inc. equity holders owned approximately 8% of the outstanding shares of the Company’s common stock.

For accounting purposes, the Merger was recognized in accordance with Accounting Standards Codification No 805-40, Reverse Acquisitions. Accordingly, PFO Global, Inc. was recognized as the accounting acquiree in the Merger, with Holding being the accounting acquirer. As such, the historical financial statements of Holding are treated as the historical financial statements of the combined company.

Debt Financings

Subsequent to the Merger, we have sold an aggregate of approximately $810.823 million in principal amount of anOriginal ~~8% original~~ issue discount senior secured convertible debentures and warrants to purchase an aggregate of 6,780,000 shares of common stock, and incurred debt issuance and debt discount costs of $01.943 million. For further details on the senior secured convertible debentures and warrants, please refer to “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Securities Purchase Agreements.”

Critical Accounting Estimates and Policies

In response to ~~financial~~Financial ~~reporting~~Reporting ~~release~~Release No, FR-60, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, from the Securities and Exchange Commission ("SEC"), we have selected our more subjective accounting estimation processes for purposes of explaining the methodology used in calculating the estimate, in addition to the inherent uncertainties pertaining to the estimate and the possible effects on our financial condition. The accounting estimates involve certain assumptions that if incorrect could have a material adverse impact on our results of operations and financial condition. See Note 1 to our condensed consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 (the “2015 Form 10-K”) for further discussion regarding our critical accounting policies and estimates. There have been no material changes to the critical accounting policies and estimates disclosed in our 2015 Form 10-K.

Our condensed consolidated financial statements have been prepared in accordance with ~~U.S.~~accounting principles generally accepted ~~accounting~~in ~~principles~~the United States of America (“GAAP”), which require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, net revenue and expenses, and the disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Senior management has discussed the development, selection and disclosure of these estimates with our board of directors and our audit committee.

An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, if different estimates reasonably could have been used, or if changes in the estimate that are reasonably likely to occur could materially impact the financial statements. We believe that the application of these policies on a consistent basis enables us to provide useful and reliable financial information about our operating results and financial condition.

3334

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), providing common revenue recognition guidance for ~~U.S.~~ GAAP. Under ASU 2014-09, an entity recognizes revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires additional detailed disclosures to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2017. We are currently evaluating the impact this standard will have on our condensed consolidated financial statements.

In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. We will adopt the methodologies prescribed by ASU 2014-15 by the date required, and we do not anticipate that the adoption of ASU 2014-15 will have a material effect on our financial position or results of operations.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We adopted this new standard as of January 1, 2016. The implementation of this standard did not have a material impact on our condensed consolidated financial statements and disclosures.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory” (ASU 2015-11”) simplifying the measurement of inventory. The guidance requires an entity to measure inventory at the lower of cost or net realizable value, which consists of estimated selling prices in the ordinary course of business, less reasonably predictable cost of completion, disposal, and transportation. The new guidance eliminates unnecessary complexity that exists under current “lower of cost or market” guidance. For public entities, ASU 2015-11 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The guidance is to be applied prospectively as of the beginning of an interim or annual reporting period, with early adoption permitted. We do not believe the implementation of this standard will have a material impact on our condensed consolidated financial statements and disclosures.

In September 2015, the FASB issued ASU No. 2015-16, “Simplifying the Accounting for Measurement Period Adjustments” (“ASU 2015-16”), which requires that adjustments to provisional amounts identified during the measurement period of a business combination be recognized in the reporting period in which those adjustments are determined, including the effect on earnings, if any, calculated as if the accounting had been completed at the acquisition date. This eliminates the previous requirement to retrospectively account for such adjustments. ASU 2015-16 also requires additional disclosures related to the income statement effects of adjustments to provisional amounts identified during the measurement period. ASU 2015-16 became effective for public companies during interim and annual reporting periods beginning after December 15, 2015 with early adoption permitted. Accordingly, we adopted this new standard on January 1, 2016. The implementation of this standard did not have a material impact on our condensed consolidated financial statements and disclosures.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”) simplifying the balance sheet classification of deferred taxes. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. Under prior guidance, an entity was required to separate deferred income tax liabilities and assets into current and non-current amounts. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected. For public entities, the guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, with early adoption permitted. The guidance may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. We adopted the new guidance on a prospective basis for the fiscal year ended December 31, 2015. Financial statements for prior periods were not retrospectively adjusted. The new guidance had no impact on our condensed consolidated financial statements.

In February 2016, the FASB issued new lease accounting guidance ASU No. 2016-02, “Leases” (“ASU 2016-02”). Under the new guidance, at the commencement date, lessees will be required to recognize a lease liability, which is a lessee’s obligation to make lease payments arising from a leases, measured on a discounted basis, and a right-to-use asset, which is an asset that represented the lessee’s right to use, or control the use of, a specified asset for the lease term. The new guidance is not applicable for leases with a term of 12 months or less. Lessor accounting is largely unchanged. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. We are currently evaluating the impact of the new guidance on our condensed consolidated financial statements.

34In June 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230), a consensus of the FASB’s Emerging Issues Task Force.” The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including interim periods within those fiscal years. An entity that elects early adoption must adopt all of the amendments in the same period. The guidance requires application using a retrospective transition method. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on the Company’s consolidated cash flows.

Results of Operations

Three months ended June 30, 2016 compared to three months ended June 30, 2015

The financial information presented in the tables below is comprised of our unaudited condensed consolidated financial information for the three months ended June 30, 2016 and 2015.

	Three months Ended June 30,
	2016			2015			% Change
Net sales	$	920,213		$	787,454			17	%
Cost of sales		687,701			495,359			39	%
Gross profit		232,512			292,095			-20	%
		25	%		37	%
Operating expenses, depreciation and amortization		1,259,345			1,893,467			33	%
Operating loss		(1,026,833	)		(1,601,373	)		-36	%
Other (income) / expense		(1,104,664	)		2,967,134			-63	%
Net loss	$	(2,131,497	)	$	(4,568,508	)		-53	%

Net sales. Net sales were $0.92 million and $0.79 million for the three months ended June 30, 2016 and 2015, respectively. The 17% increase was due primarily to an increase in the volume of sales of prescription lenses and complete eyewear.

Cost of Sales. Cost of sales was $0.69 million and $0.50 million for the three months ended June 30, 2016 and 2015, respectively. The increase in costs was primarily due to increased volume of complete eyewear.

Gross Profit. Gross profit was $0.23 million and $0.29 million for the three months ended June 30, 2016 and 2015, respectively. The decrease was due primarily to lower gross margins from changes in our product mix.

Operating Expenses. Operating expenses, exclusive of cost of sales, were $1.26 million and $1.89 million for the three months ended June 30, 2016 and 2015, respectively. This decrease was due primarily to a $0.59 million decrease in personnel costs as a result of cost reductions initiated in November 2015, a $0.10 decrease in legal and professional fees partially offset by a $0.08 million increase in selling, general and administrative expenses and a $0.03 million decrease in bad debt expenses. These changes are illustrated in the table below.

	Three months Ended June 30,
	2016		2015		% Change
Personnel costs	$	428,418	$	1,013,926		-58	%
General and administrative		402,934		319,054		-26	%
Legal and professional		280,479		381,295		-26	%
Sales and marketing		55,515		30,264		83	%
Depreciation and amortization		20,576		51,453		-60	%
Bad debt expense		71,423		97,476		-27	%
Total operating expenses	$	1,259,345	$	1,893,468		-33	%

Other Expense. Other Expense was $1.1 million and $3.0 million for the three months ended June 30, 2016 and 2015, respectively. This decrease is due primarily to a $0.92 million decrease in the change in the fair value of derivative instruments, a $0.58 million decrease in debt extinguishment expense, a $0.40 million decrease in debt discount and issuance costs and a $0.21 million decrease in other expenses, offset by a $0.24 million increase in interest expense related to additional debt.

~~Six~~Results ~~months~~of ~~ended June 30, 2016 compared to six months ended June 30, 2015~~Operations

~~The~~Three ~~financial~~months ~~information~~ended ~~presented~~September in30, ~~the~~2016 ~~tables~~compared ~~below~~to isthree ~~comprised of our unaudited condensed consolidated financial information for the six~~ months ended ~~June~~September 30, ~~2016 and~~ 2015.

	Six months Ended June 30,
	2016			2015			% Change
Net sales	$	2,005,600		$	1,771,623			13	%
Cost of sales		1,263,000			1,022,277			24	%
Gross profit		742,600			749,346			-1	%
		37	%		42	%
Operating expenses, depreciation and amortization		2,563,610			4,048,957			37	%
Operating loss		(1,821,011	)		(3,299,611	)		45	%
Other (income) / expense		(1,725,825	)		(3,832,831	)		-55	%
Net loss	$	(3,546,836	)	$	(7,132,442	)		50	%

The financial information presented in the tables below is comprised of our unaudited condensed consolidated financial information for the three months ended September 30, 2016 and 2015.

Net sales. Net sales were $2.0 million and $1.77 million for the six months ended June 30, 2016 and 2015, respectively. The 13% increase was due primarily to an increase in the volume of sales of prescription lenses and complete eyewear.

	Three Months Ended September 30,
	2016			2015			% Change
Net sales	$	789,530		$	710,050			11	%
Cost of sales		577,759			508,191			14	%
Gross profit		211,771			201,859			5	%
		27	%		28	%
Operating expenses, depreciation and amortization		1,357,847			2,300,660			-41	%
Operating loss		(1,146,076	)		(2,098,801	)		-45	%
Other (income) / expense		(42,870	)		(1,741,234	)		-98	%
Net loss	$	(1,188,946	)	$	(3,840,035	)		-69	%

~~Cost~~Net ~~of Sales~~sales. ~~Cost~~Net of sales ~~was~~were $10.2679 million and $1.0.71 million for the ~~six~~three months ended ~~June~~September 30, 2016 and 2015, respectively. The 11% increase ~~in costs~~ was ~~primarily~~ due primarily to ~~increased~~an increase in the volume of sales of prescription lenses and complete eyewear.

~~Gross~~Cost ~~Profit~~of Sales. ~~Gross~~Cost ~~profit~~of sales was $0.7458 million and $0.7551 million for the ~~six~~three months ended ~~June~~September 30, 2016 and 2015, respectively. The ~~decrease was~~increase ~~due~~in costs was primarily due to ~~lower~~increase ~~margins~~in ~~from~~the ~~changes~~volume inof ~~our~~sales ~~product~~of ~~mix~~prescription lenses and complete eyewear.

~~Operating~~Gross ~~Expenses~~Profit. ~~Operating~~Gross ~~expenses,~~profit ~~exclusive~~was ~~of cost of sales, were~~ $20.5621 million and $4.0.20 million for the ~~six~~three months ended ~~June~~September 30, 2016 and 2015, respectively. ~~This~~The ~~decrease~~ increase was due primarily to aincreased ~~$1.2~~volume ~~million~~of ~~decrease~~sales ~~in personnel costs as a result~~ of ~~cost~~prescription ~~reductions~~lenses ~~initiated in November 2015,~~ and acomplete $0eyewear.~~30 million decrease in selling, legal, general and administrative expenses, partially offset by $0.03 million increase in bad debt expenses. These changes are illustrated in the table below.~~

	Six months Ended June 30,
	2016		2015		% Change
Personnel costs	$	903,153	$	2,117,320		-57	%
General and administrative		832,614		950,021		12	%
Legal and professional		513,614		579,499		11	%
Sales and marketing		110,875		182,989		39	%
Depreciation and amortization		74,863		119,608		37	%
Bad debt expense		128,492		99,520		29	%
Total operating expenses	$	2,563,611	$	4,048,957		37	%

Operating Expenses. Operating expenses were $1.36 million and $2.3 million for the three months ended September 30, 2016 and 2015, respectively. This decrease was due primarily to a $0.65 million decrease in personnel costs because of cost reductions initiated in November 2015, a $0.11million decrease in legal and professional fees, a $0.07 million decrease in selling, general and administrative expenses, and a $0.11 million decrease in bad debt expense. These changes are illustrated in the table below.

Other Expense. Other Expense was $1.73 million and $3.83 million for the six months ended June 30, 2016 and 2015, respectively. This decrease is due primarily to a $0.68 million decrease in the change in the fair value of derivative instruments, a $0.60 million decrease in debt extinguishment expense, and a $1.27 million decrease in debt discount and issuance costs, offset by a $0.58 million increase in interest expense and original issue discounts related to additional debt and a $0.19 million decrease in other expenses.

	Three months Ended September 30,
	2016			2015		% Change
Personnel costs	$	434,709		$	1,085,634		-60	%
General and administrative		436,513			586,961		-26	%
Legal and professional		367,966			480,382		-23	%
Sales and marketing		205,969			89,783		129	%
Depreciation and amortization		20,510			57,900		-65	%
Bad debt expense		(107,820	)		-		0	%
Total operating expenses	$	1,357,847		$	2,300,660		-41	%

Other Expense. Other Expense was $.04 million and $1.74 million for the three months ended September 30, 2016 and 2015, respectively. This decrease is due primarily to a $1.58 million increase in the change in fair value of derivative instruments, and a $0.19 million decrease in interest expense (including amortization of debt discount and issuance costs), partially offset by a $0.07 million decrease in other income.

Nine months ended September 30, 2016 compared to nine months ended September 30, 2015

The financial information presented in the tables below is comprised of our unaudited condensed consolidated financial information for the nine months ended September 30, 2016 and 2015.

	Nine months Ended September 30,
	2016			2015			% Change
Net sales	$	2,795,130		$	2,160,730			29	%
Cost of sales		1,840,759			1,530,468			20	%
Gross profit		954,371			630,262			51	%
		34	%		29	%
Operating expenses, depreciation and amortization		3,921,458			6,349,617			-38	%
Operating loss		(2,967,087	)		(5,719,355	)		-48	%
Other (income) / expense		(1,768,695	)		(5,253,122	)		-66	%
Net loss	$	(4,735,782	)	$	(10,972,477	)		-57	%

Net sales. Net sales were $2.80 million and $2.16 million for the nine months ended September 30, 2016 and 2015, respectively. The 29% increase was due primarily to an increase in the volume of sales of prescription lenses and complete eyewear.

Cost of Sales. Cost of sales was $1.84 million and $1.53 million for the nine months ended September 30, 2016 and 2015, respectively. The increase in costs was primarily due to increase in the volume of sales of prescription lenses and complete eyewear.

Gross Profit. Gross profit was $0.95 million and $0.63 million for the nine months ended September 30, 2016 and 2015, respectively. The increase was due primarily to increased volume of sales of prescription lenses and complete eyewear and better inventory management.

Operating Expenses. Operating expenses, exclusive of cost of sales, were $3.92 million and $6.35 million for the nine months ended September 30, 2016 and 2015, respectively. This decrease was due primarily to a $1.87 million decrease in personnel costs as a result of cost reductions initiated in November 2015, a $0.53 million decrease in legal, general and administrative expenses, a $0.08 million decrease in depreciation and amortization and a decrease of $0.08 million in bad debt expense, partially offset by $0.13 million increase in sales and marketing expenses. These changes are illustrated in the table below.

	Nine months Ended September 30,
	2016		2015		% Change
Personnel costs	$	1,337,862	$	3,202,954		-58	%
General and administrative		1,186,576		1,536,982		-23	%
Legal and professional		880,844		1,059,881		-17	%
Sales and marketing		400,130		272,772		47	%
Depreciation and amortization		95,374		177,508		-46	%
Bad debt expense		20,672		99,520		-79	%
Total operating expenses	$	3,921,458	$	6,349,617		-38	%

Other Expense. Other Expense was $1.77 million and $5.25 million for the nine months ended September 30, 2016 and 2015, respectively. This decrease is due primarily to a $2.26 million increase in the change in fair value of derivative instruments, a $0.58 million decrease in debt extinguishment loss, and a $0.79 million decrease in interest expense (including amortization of debt discount and issuance costs), partially offset by a $0.15 decrease in other income.

Liquidity and Capital Resources

The following table sets forth the major sources and uses of cash for each of the periods set forth below:

	Six Months Ended June 30,
	Nine months Ended September 30,
	2016			2015
Cash and cash equivalents	$	33130,~~056~~413		$	8330,~~851~~849
Net cash used in operating activities		(13,~~881~~011,~~253~~705	)		(25,~~104~~753,~~150~~088	)
Net cash used in investing activities		-(60,701	)		(4163,~~216~~092	)
Net cash provided by financing activities		13,~~888~~176,~~059~~569			26,~~078~~071,~~681~~493
Net increase (decrease) in cash and cash equivalents	$	6,806		$	(66,685	)
Net increase in cash and cash equivalents	$	104,163		$	255,313

Historically, we have financed our operations primarily through private placements of our equity and borrowings under various debt instruments. For the ~~six~~nine months ended ~~June~~September 30, 2016, we used $13.901 million of cash in operating activities and ended the period with $33130,~~056~~413 in cash and cash equivalents. As of ~~June~~September 30, 2016, we had a working capital deficit of approximately $~~17.1~~23 million. We currently use approximately $~~643~~650,000 per month for continuing operations, which includes general operating expenses (office lease, utilities, salary and insurance), promotion and marketing (travel, entertainment, meals and website development), ~~prototype development (parts, engineering~~ and ~~testing), and~~ professional services (accounting, legal, professional and state fees and intellectual property fees). We expect this rate to remain relatively consistent for the next twelve months.

We believe that we have the ability to raise additional capital that will be sufficient to meet our anticipated cash needs for at least the next 12 months, although there are no assurances that we will be able to raise the capital on terms acceptable to us or at all. We have raised approximately $1.098 million, net of debt discounts, through the issuance of convertible debentures subsequent to June 30, 2016. If we are unable to raise additional capital, our business, operating results, and financial condition would be materially adversely affected. These factors raise substantial doubt about our ability to continue as a going concern. For information regarding our ability to continue as a going concern, please refer to Note 2 to our condensed consolidated financial statements contained in this Quarterly Report on Form 10-Q.

Our primary source of operating funds since inception has been cash proceeds from issuance of notes payable. We believe that we will have the ability to raise additional capital through private placements of debt and equity securities that will be sufficient to meet our anticipated cash needs for at least the next twelve months, although there are no assurances that we will be able to raise the capital on terms acceptable to us or at all, or will be sufficient to enable us to fully complete our development activities or sustain operations. We have raised approximately $3.1 million, net of repayments and debt issuance costs, in the nine month period ended September 30, 2016 and $385,000, net of debt issuance costs, through the issuance of convertible debentures subsequent to September 30, 2016. If we are unable to raise additional capital, our business, operating results, and financial condition would be materially adversely affected.

Management believes that the actions presently being taken by us will provide sufficient liquidity for us to continue to execute our business plan. However, there can be no assurances that management’s plans will be achieved. If we are unable to raise sufficient additional funds, we will have to develop and implement a plan to further extend payables, reduce overhead, or scale back our current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

Operating Activities

For the ~~six~~nine months ended ~~June~~September 30, 2016, operating activities used $13.901 million in cash as a result of (a) a net loss of $34.574 million, adjusted by non-cash items such as amortization of debt discount and debt issuance costs of $1.279 million, change in the fair value of derivative instruments of $(01.~~64)~~77 million, options issued in exchange for compensation and services of $0.07 million, accrual of interest due to related parties of $0.1522 million, accrual of interest due to third parties of $1.4 million, depreciation and amortization of $0.0710 million and provision for doubtful accounts of $0.1302 million and (b) aan ~~decrease~~increase in working capital of $0.1726 million.

For the ~~six~~nine months ended ~~June~~September 30, 2015, operating activities used $25.18 million in cash as a result of (a) a net loss of $711.10 million, adjusted by non-cash items such as amortization of debt discount and debt issuance costs of $23.2 million, loss on extinguishment of debt of $0.6 million, change in the fair value of derivative instruments of $0.5 million, shares issued in exchange for services of $0.2 million, a $0.2 million write off of prepaid IPO costs, accrual of interest due to related parties of $0.12 million, accrual of interest due to third parties of $0.98 million, depreciation and amortization of $0.118 million and provision for doubtful accounts of $0.1 million. ~~This~~and ~~net~~(b) ~~cash use was partially offset by~~ an ~~increase~~decrease in ~~operating~~working ~~cash~~capital ~~generated by changes in other operating assets and liabilities~~ of $10.413 million.

Investing Activities

For the ~~six~~nine months ended ~~June~~September 30, 2016 and ~~June~~September 30, 2015 we used $0.06 and $0.0406 million respectively, for the purchase of business software, servers, network, and lab and production equipment. ~~not use any cash for investing activities.~~

Financing Activities

Our financing activities for the ~~six~~nine months ended ~~June~~September 30, 2016, resulted in net cash of $13.8818 million related to net proceeds of $13.9627 million from issuance of various notes payable, partially offset by $0.7807 million in debt issue costs and $0.02 million in loan repayments and debt issue costs.

Our financing activities for the six months ended June 30, 2015 resulted in net cash of $2.1 million related to net proceeds of $2.2 million from issuance of various notes payable, partially offset by $0.1 million in loan repayments 38

Notes Payable

As of ~~June~~September 30, 2016, the principal amount due under our promissory notes was $2116.67 million, before debt discounts and debt issuance costs of $21.6 million. ~~The following table provides information regarding annual required repayments under the promissory notes, as of June 30, 2016, which is discussed below.~~

2016	$	10,668,569
2017		5,489,041
2018		5,483,196
	$	21,640,806

The following table provides information regarding annual required repayments under the notes payable as of September 30, 2016:

2016	$	6,705,000
2017		6,827,236
2018		3,170,434
	$	16,702,670

Convertible Promissory Note

3839

Promissory Note

Series A Private Placement

On various dates from May 1, 2014 through September 19, 2014, the Company issued and sold 299.25 investment units to accredited investors (the “Series A Private Placement”). Each investment unit was sold at a purchase price of $10,000 and consisted of (i) a Series A secured promissory note in the principal amount of $10,000 (collectively the “Series A Note”), (ii) a five-year Class A warrant to purchase 6,250 shares of common stock at an exercise price of $1.60 per share, exercisable in whole or in part as of the date of issuance (collectively the “Class A Warrants”), and (iii) five-year Class B warrants to purchase 1,756.6 shares of common stock at an exercise price of $0.01 per share, exercisable in whole or in part as of the date of issuance(collectively the “Class B Warrants”). Proceeds received from the Series A Private Placement were approximately $2,633,000 net of related costs of approximately $360,000.

3940

Secured Bridge Private Placement

In May 2015, the Bridge Notes were amended, modifying the maturity date of the Bridge Notes such that each Bridge Note matures on the earlier of: (i) the receipt of funds from accounts receivable in the aggregate principal amount then outstanding of all Bridge Notes; (ii) the receipt of gross proceeds from any accounts receivable financing or factoring financing in an amount equal to at least the aggregate Bridge Note principal; (iii) thirty (30)days following the funding of any financing that results in a listing of the Company’s common stock on a national exchange; (iv) the sale by the Company of all or substantially all the Company’s assets in one transaction or in a series of related transactions; (v) the completion of any acquisition, merger or consolidation of the Company in which the collective ownership of the Company in the transaction would own, in the aggregate, a lower percentage of the total combined voting power of the surviving entity than the acquiring company’s collective ownership; and (vi) January 1, 2016.

Convertible Notes Private Placement

The terms of the Class C Warrants provide that the exercise price of each warrant shall be (i) if the warrant ~~becomes~~is ~~exercisable~~exercised on the Company’s initial public offering date, 110% of the per warrant share offering price of the Company’s securities in its initial public offering, (ii) if the warrant is exercised upon the occurrence of an acquisition of the Company, the lower of (x) 20% discount to the warrant share valuation in the acquisition and (y) a per warrant share price based on a fully diluted market capitalization value of one hundred million dollars ($100,000,000) on the date of the acquisition, and (iii) if the warrant is exercised on June 30, 2015, a per warrant share price based on a fully diluted market capitalization value of one hundred million dollars ($100,000,000) on June 30, 2015. NTHB: I deleted the phrase in the first paragraph] At the time of issuance, the Company determined that the variable exercise price feature on the Class C Warrants constituted a derivative liability because the variable exercise price feature represents a variable conversion feature.

4041

Proceeds received from the Convertible Note Private Placement were approximately $1,565,000, net of related costs of approximately $230,000.

Short-Term Promissory Note

In May 2015, the Company entered into a promissory note (“Short-Term Promissory Note”) for a principal amount of $100,000 with a stated interest rate of 9%.

In conjunction with the Short-Term Promissory Note, the Company issued (i) five year Class A Warrants to purchase an aggregate of 62,500 common shares at an exercise price of $1.60 per share and (i) five year Class B Warrants to purchase an aggregate of 17,566 common shares at an exercise price of $0.01 per share. In conjunction with the amendment, in June 2015, the Company issued five year Class A Warrants to purchase an aggregate of 62,500 common shares to the note holder and approximately 5,000 common shares to the private placement agent.

Promissory Note

The Company was unable to make the July 1, 2016 principal payment. ~~and~~Based ison ~~currently negotiating with~~ the ~~Royalty~~Company’s ~~Obligation~~current ~~purchaser~~financial ~~for an extension of the maturity date~~condition, ~~although~~ there can be no ~~guarantee~~certainty that ~~we will be successful in such negotiations or that~~ the ~~terms~~Company ~~of any such extension~~ will be ~~acceptable~~able to ~~us.~~make ~~Based on~~ the ~~Company’s~~payment ~~current~~and ~~financial~~is ~~condition,~~currently ~~there~~negotiating ~~can~~with bethe noRoyalty ~~certainty~~Obligation ~~that~~purchaser ~~the~~for ~~Company~~an ~~will~~extension beof ~~able~~the tomaturity ~~make~~date. ~~the payment~~

Securities Purchase Agreements

On various dates from June 30, 2015 through ~~December~~September 3130, ~~2015~~2016, the Company entered into a series of securities purchase agreements (each, a “Securities Purchase ~~Agreements~~Agreement” (and collectively, the “~~2015~~ Securities Purchase Agreements”) with Hillair Capital Investment L.P. (the “Investor”), pursuant to which the Company sold a series of original issue discount senior secured convertible debentures (each, a “Debenture” and collectively, the “Debentures”). Pursuant to the Securities Purchase Agreements dated June 30, 2015 through December 31, 2015, the Company sold an aggregate of $6,580,000 in principal amount of anDebentures ~~8% original issue discount senior secured convertible debenture,~~ dated July 1, 2015, (to the ~~“Debenture”),~~Investor for an aggregate purchase price of $65,~~145~~875,000 ~~to the Investor~~. Pursuant to the Securities Purchase ~~Agreement~~Agreements dated June 30, 2015 through December 31, 2015, the Company also issued warrants to the Investor ~~warrants, (the “SPA Warrant”),~~ to purchase an aggregate of 3,290,000 shares of ~~our~~the Company’s common stock (subject to adjustment) (collectively, the “Investor Warrants”). The ~~Debenture~~Debentures ~~matures~~sold in 2015 mature on January 1, 2017, and ~~accrues~~accrue interest at the rate of 8% per annum. One quarter of the original principal amount of the ~~Debenture~~Debentures sold in 2015 is payable on each of July 1, 2016 and October 1, 2016, and the remaining principal amount of the ~~Debenture~~Debentures sold in 2015 is payable on January 1, 2017. 8% ~~Accrued~~accrued interest on the ~~Debenture~~Debentures sold in 2015 is payable on January 1, April 1, July 1 and October 1 of each year, commencing on April 1, 2016.

The Company did not make its April 1, 2016 and July 1, 2016 interest payments under the Debenture and the principal payment due on July 1, 2016. The Company has received a waiver from the Investor extending the interest and principal payments to January 1, 2017. Based on the Company’s current financial condition, there can be no certainty that the Company will be able to make the delinquent interest and principal payments and accordingly the outstanding principal amount due under the Debenture has been presented as current in the Company’s condensed consolidated balance sheets.

On January 7, 2016 the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $504,000 in principal amount of a Debenture for an aggregate purchase price of $450,000 to the Investor. The Debenture matures on February 1, 2017, and accrues interest at the rate of 8% per annum. No warrants were granted related to these issuances in 2016.

On February 17, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $616,000 in principal amount of a Debenture for an aggregate purchase price of $550,000 to the Investor. The Debenture matures on March 1, 2017, and accrues interest at the rate of 8% per annum. No warrants were granted related to these issuances in 2016.

On April 14, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $828,000 in principal amount of a Debenture for an aggregate purchase price of $740,000 to the Investor. The Debenture matures on May 1, 2017, and accrues interest at the rate of 8% per annum. After taking into account legal and diligence fees of $27,500 reimbursed to the Purchaser, the net proceeds received by the Company was $712,500. No warrants were granted related to these issuances in 2016.

On June 13, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $252,000 in principal amount of a Debenture for an aggregate purchase price of $225,000 to the Investor. The Debenture matures on July 1, 2017, and accrues interest at the rate of 8% per annum. No warrants were granted related to these issuances in 2016.

Proceeds received from the Debentures were approximately $1,906,000, net of related costs of approximately $59,000 and original issue discounts of $235,000 respectively, during the six months ended June 30, 2016. Debt issuance costs will be amortized to interest expense over the life of the Debentures.

Amounts of principal and accrued interest under the Debenture are convertible at the option of the Investor at any time into shares of our common stock at an initial conversion price (as may be adjusted, the “Conversion Price”) of $2.00 per share, subject to certain ownership limitations and adjustment provisions. The Conversion Price is subject to reduction to an amount equal to 90% of the effective price per share of securities issued by the Company (i) in a registered offering of our common stock or securities convertible into or exchangeable for shares of our common stock (collectively “Common Stock Equivalents”) or (ii) in any other financing or series of financings of our common stock or Common Stock Equivalents with gross proceeds of $4,000,000 or more (each, a “Triggering Event”). Beginning six months after the original issue date for each Debenture, the Company has the option, subject to certain conditions, to redeem some or all of the then outstanding principal amount of the Debenture for cash in an amount equal to the sum of (i) 120% of the then outstanding principal amount of such Debenture, (ii) accrued but unpaid interest and (iii) any liquidated damages and other amounts due in respect of such Debenture.

~~Pursuant~~The toCompany did not make its April 1, 2016 or July 1, 2016 interest payments or the ~~terms~~July of1, 2016 principal payment under the ~~Debenture~~Debentures sold in 2015. On July 8, 2016, the Company ~~has~~received ~~agreed~~a towaiver ~~certain~~from ~~negative~~the ~~covenants,~~Investor ~~including~~extending ~~not~~any scheduled interest and principal payments to ~~incur~~January or1, ~~repay~~2017. ~~any~~Based ~~other~~on ~~indebtedness~~the Company’s current financial condition, ~~for~~there socan ~~long~~be asno ~~any~~certainty ~~portion~~that ofthe Company will be able to make the ~~Debenture~~delinquent ~~remains~~interest and principal payments and accordingly the outstanding principal amount due under the Debentures sold in 2015 has been presented as current in the Company’s condensed consolidated balance sheets.

~~Each~~On ofJanuary ~~the SPA Warrants (collectively~~7, ~~the~~2016 ~~“Investor Warrants”) is exercisable for a period of five years from~~ the ~~original~~Company ~~issue~~entered ~~date~~into ~~of each Investor Warrant, at~~ an ~~initial~~additional ~~exercise~~Securities ~~price~~Purchase ~~(the~~Agreement ~~“Investor~~with ~~Warrant Exercise Price”) of $2.40 per share. In addition to customary adjustments for stock splits and~~ the ~~like~~Investor, ifpursuant ~~a Triggering Event occurs, the Investor Warrant Exercise Price is subject~~ to ~~reduction~~which to the ~~Conversion~~Company ~~Price~~sold ~~applicable~~an asaggregate ~~a result~~ of ~~such Triggering Event~~$504,000 in ~~which~~principal ~~event~~amount ~~the number~~ of ~~shares~~a ofDebenture ~~common~~for ~~stock~~an ~~issuable under the Investor Warrants would be increased such that the~~ aggregate ~~Investor~~purchase ~~Warrant~~price ~~Exercise~~of ~~Price payable under the Investor Warrants~~$450,000 ~~after taking into account the decrease in the Investor Warrant Exercise Price, would be equal~~ to the ~~aggregate~~ Investor ~~Warrant Exercise Price prior to such adjustment~~. IfThis atDebenture ~~any~~matures ~~time~~on ~~after~~February ~~the~~1, ~~six~~2017, ~~month~~and ~~anniversary~~does ofnot ~~the~~bear ~~original~~interest ~~issue~~but ~~date~~has ~~for~~an ~~each Investor Warrant there is no~~ effective ~~registration~~interest ~~statement~~rate ~~registering, or no current prospectus available for, the resale~~ of ~~the~~12% ~~shares~~per ~~of common stock underlying the Investor Warrant, then such Investor Warrant may be exercised, in whole or in part, at such time on a “cashless exercise” basis~~annum.

On February 17, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $616,000 in principal amount of a Debenture for an aggregate purchase price of $550,000 to the Investor. This Debenture matures on March 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum.

On April 14, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $828,800 in principal amount of a Debenture for an aggregate purchase price of $740,000 to the Investor. This Debenture matures on May 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum. After taking into account legal and diligence fees of $27,500 reimbursed to the Purchaser, the net proceeds received by the Company was $712,500.

On June 13, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $252,000 in principal amount of a Debenture for an aggregate purchase price of $225,000 to the Investor. This Debenture matures on July 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum.

On July 8, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $616,000 in principal amount of a Debenture for an aggregate purchase price of $550,000 to the Investor. This Debenture matures on July 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum.

On August 16, 2016, the Company entered into an additional Securities Purchase Agreement with the Investor, pursuant to which the Company sold an aggregate of $448,000 in principal amount of a Debenture for an aggregate purchase price of $400,000 to the Investor. The Debenture matures on August 1, 2017, and does not bear interest but has an effective interest rate of 12% per annum.

Pursuant to the terms of the Debentures, the Company has agreed to certain negative covenants, including not to incur or repay any other indebtedness, for so long as any portion of the Debenture remains outstanding.

Each of the Investor Warrants is exercisable for a period of five years from the original issue date of each Investor Warrant, at an initial exercise price of $2.40 per share (the “Investor Warrant Exercise Price”). In addition to customary adjustments for stock splits and the like, if a Triggering Event occurs, the Investor Warrant Exercise Price is subject to reduction to the Conversion Price applicable as a result of such Triggering Event, in which event the number of shares of common stock issuable under the Investor Warrants would be increased such that the aggregate Investor Warrant Exercise Price payable under the Investor Warrants, after taking into account the decrease in the Investor Warrant Exercise Price, would be equal to the aggregate Investor Warrant Exercise Price prior to such adjustment. If at any time after the six month anniversary of the original issue date for each Investor Warrant there is no effective registration statement registering, or no current prospectus available for, the resale of the shares of common stock underlying the Investor Warrant, then such Investor Warrant may be exercised, in whole or in part, at such time on a “cashless exercise” basis.

4344

Royalty Obligation

On June 25, 2014, The Company entered into a ~~Royalty~~royalty ~~Purchase~~purchase ~~Agreement~~agreement (the “Royalty Obligation”) with a third party (“Purchaser”) as amended in May and June 2015. Under the terms of the amended Royalty ~~Purchase Agreement~~Obligation, the Company was advanced $1,750,000 by the Purchaser and in return, the Company agreed to pay the Purchaser a royalty amount equal to 3.09% of monthly revenue generated from products or services that incorporate any of the Company's intellectual property ("IP Revenue") including patents, copyrights and trademarks in perpetuity ("Royalty Payments"). No monthly Royalty Payments for any calendar month will be less than $36,458.

The monthly royalty payments were deferred from April 2015 through June 2016 and were due on July 1, 2016.

RELATED PARTY NOTES

AsLong-term ofnotes ~~June 30, 2016, we had an outstanding aggregate principal amount of $4.6 million~~ due to related parties, ~~consisting~~consist of the following:

	June 30, 2016		December 31, 2015
	September 30, 2016		December 31, 2015
The Company has a unsecured note payable with HP Equity Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrue at 4.5% per annum.	$	1,030,639	$	1,030,639
The Company has an unsecured note payable with HP Equity Fund LLC pursuant to the Optix Plan of Reorganization. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrue at 4.5% per annum.	$	1,030,639	$	1,030,639
The Company has a note payable with HCA Capital Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note payable is secured by substantially all of the assets of the Company. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrues at 9.5% per annum.		448,993		448,993
The Company has a note payable with HCA Capital Fund LLC pursuant to the Optix Plan of Reorganization. The note payable is secured by substantially all of the assets of the Company. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Interest continues to accrues at 9.5% per annum.		448,993		448,993
The Company has a unsecured note payable with PFO Fund LLC pursuant to Plan of Reorganization dated May 2, 2011. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrues at 4.5% per annum.		206,565		206,565
The Company has an unsecured note payable with PFO Fund LLC pursuant to the Optix Plan of Reorganization. The note does not carry any cross default provisions. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrues at 4.5% per annum.		206,565		206,565
The Company has a promissory note with Transition Capital, LLC dated September 1, 2012, as amended. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrue at 5.5% per annum		1,550,200		1,550,200
The Company has a promissory note with Transition Capital, LLC dated September 1, 2012, as amended. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. Such amendment was accounted for as a modification of debt. Interest continues to accrue at 5.5% per annum.		1,550,200		1,550,200
The Company has an unsecured promissory note with Atlas Technologies, AG which is owned by a relative of the Company’s former Chief Executive Officer (“CEO”) dated December 30, 2012 at a stated annual interest rate of 5.5%. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		117,700		117,700

4445

	June 30, 2016		December 31, 2015
	September 30, 2016		December 31, 2015
The Company has an agreement with its former CEO effective February 2011 to pay an automobile allowance of $1,633 per month through the date of termination. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. The note was settled pursuant to the termination agreement as disclosed below)		-		52,108
The Company has an agreement with its former CEO effective February 2011 to pay an automobile allowance of $1,633 per month through the date of termination. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018. The note was settled pursuant to the consulting agreement entered into with the Company’s former CEO.		-		52,108
The Company has a promissory note with a relative its former CEO effective September 6, 2011 at a stated annual interest rate of 0%. In June 2015, the Company amended the maturity date of the note such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		47,210		47,210
The Company has three promissory notes with three stockholders dated July 2011 at a stated annual interest rate of 9.5%. In June 2015, the Company amended the maturity date of the July 2011 notes such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		1,134,~~214~~215		1,134,215
The Company has four promissory notes with four stockholders dated May 2015 at a stated annual interest rate of 4.5%. In June 2015, the Company amended the maturity date of the July 2011 notes such that half of the principal matures on July 1, 2017 and the remainder matures on January 1, 2018.		90,000		90,000
Total long term notes to related parties		4,625,~~521~~522		4,677,630
Less current maturities		-2,312,761		-
Total long term notes to related parties, net of current maturities	$	42,~~625~~312,~~521~~761	$	4,677,630

The following table provides information regarding annual required repayments under the ~~related~~notes ~~party~~payable, ~~notes~~as amended, as of ~~June~~September 30, 2016:

2016	$	-
2017		2,312,761
2018		2,312,~~760~~761
Total	$	4,625,521
	$	4,625,522

As of June 30, 2016, the amount outstanding under the Company’s royalty obligation agreement was $1.75 million. For information regarding such notes, please refer to Note 6 to our condensed consolidated financial statements contained in this Report.

Off-Balance Sheet Arrangements

We do not engage in any off-balance sheet financing activities, nor do we have any interest in entities referred to as variable interest entities.

Impact of Inflation

We believe that inflation has not had a material impact on our results of operations for the ~~six~~nine months ended ~~June~~September 30, 2016 and 2015. We cannot assure you that future inflation will not have an adverse impact on our operating results and financial condition.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Market risk represents the risk of loss that may result from the change in value of financial instruments due to fluctuations in market prices. Market risk is inherent in all financial instruments. Market risk may be exacerbated in times of trading illiquidity when market participants refrain from transacting in normal quantities and/or at normal bid-offer spreads. Our exposure to market risk is directly related to derivatives, debt and equity linked instruments related to our financing activities.

Our assets and liabilities are overwhelmingly denominated in U.S. dollars. We do not use foreign currency contracts or other derivative instruments to manage changes in currency rates. We do not now, nor do we plan to, use derivative financial instruments for speculative or trading purposes. However, these circumstances might change.

We do not hold or issue derivatives, derivative commodity instruments or other financial instruments for speculative trading purposes. Further, we do not believe our cash equivalents have significant risk of default or illiquidity. Although we believe our cash equivalents and investment securities do not contain excessive risk, we cannot provide absolute assurance that in the future our investments will not be subject to adverse changes in market value. All of our cash equivalents are recorded at fair value.

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we might not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.

4546

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Principal Executive Officer and Principal Financial Officer conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that as of ~~June~~September 30, 2016, in light of the material weaknesses described below, our disclosure controls and procedures were not effective as of ~~June~~September 30, 2016. See material weaknesses discussed below in Management’s Report on Internal Control over Financial Reporting.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 as of December 31, 2015.

Our internal control over financial reporting is a process designed under the supervision of our Principal Executive Officer and Principal Financial Officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

Our Company did not maintain, in all material respects, effective internal control over financial reporting as of ~~June~~September 30, 2016, because we continued to have the following material weaknesses:

• Did not maintain sufficient and competent personnel with an appropriate level of experience and training in the application of US GAAP and SEC rules and regulations

•

Did not have sufficient segregation of duties or compensating controls in the accounting and finance function due to limited personnel

•

Did not maintain adequately designed internal controls in order to prevent or detect and correct material misstatements to the financial statements, including internal controls related to complex or nonroutine transactions

•

Lacked documentation to support occurrences of monitoring processes and approval procedures, in order to demonstrate that internal controls were operating effectively

Management believes that despite our material weaknesses, our consolidated financial statements for the ~~six~~nine months ended ~~June~~September 30, 2016 are fairly stated, in all material respects, in accordance with GAAP.

Changes in Internal Control over Financial Reporting

Other than as described above, there were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, that occurred during the quarter ended ~~June~~September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

Management, including our CEO and CFO, does not expect that disclosure controls and internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls.

4647

The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

PART II

Item 1.

Legal Proceedings

~~There~~For ~~have~~a ~~been~~description noof material ~~developments~~pending inlegal proceedings, see the ~~legal~~discussion ~~proceedings~~set ~~previously~~forth ~~disclosed~~under the heading “Litigation” in ~~our~~Note ~~Quarterly~~9 ~~Report~~to onour ~~Form~~Consolidated ~~10-Q~~Financial ~~for~~Statements, ~~the~~which ~~period~~is ~~ended~~incorporated ~~March~~by ~~31,~~reference ~~2016~~herein.

Item 1A.

Risk Factors

There have been no material changes to the risk factors disclosed under “Item 1A. Risk Factors” of our 2015 Form 10-K. For additional information concerning our risk factors, please refer to “Item 1A. Risk Factors” of our 2015 Form 10-K.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.

Defaults upon Senior Securities

None

Item 4.

Mine Safety Disclosure

None

Item 5. Other Information December Option Grant On December 10, 2015, we issued a non-qualified option to purchase 1,017,000 shares of common stock (the “December Option”) under our 2015 Stock Option Plan (the “2015 Plan”), to be exercised at $0.30 per share. The December Option was exercisable with respect to all shares on the date of the grant and expires on December 31, 2020. The December Option was approved by our board of directors and was awarded pursuant to a stock option award agreement, which was executed by the Company and Mr. Suter on December 10, 2015. The issuance and sale of the December Option was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, because the transaction did not involve a public offering. We did not engage in general solicitation or advertising with regard to the issuance and sale of the December Option. April Option Grant On April 1, 2016, we entered into a consulting agreement with Mr. Suter, our former CEO, pursuant to which Mr. Suter agreed to provide certain advisory services in exchange for 3% of net sales that he generates. Such commission will be paid in the form of (i) $65,000 in cash and (ii) a non-qualified option to purchase 400,000 shares of common stock (the “April Option”) under the 2015 Stock Option Plan, to be exercised at $0.30 per share in full and final settlement of deferred salary and allowances, net of fees and other amounts due to the Company. The April Option was exercisable with respect to all shares on the date of the grant and expires on December 31, 2020. The April Option was approved by our board of directors and was awarded pursuant to a stock option award agreement, which was executed by the Company and Mr. Suter on April 1, 2016. The issuance and sale of the April Option was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, because the transaction did not involve a public offering. We did not engage in general solicitation or advertising with regard to the issuance and sale of the April Option

None

Item 6.

Exhibits

A list of exhibits filed herewith is contained in the Exhibit Index that immediately precedes such exhibits and is incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	PFO GLOBAL, INC.

	By:	/s/ Matthew Cevasco
		Matthew Cevasco
		President and Chief Executive Officer

By: /s/ ~~Brigitte~~Mahesh ~~Rousseau~~Shetty ~~Brigitte~~Mahesh ~~Rousseau~~Shetty Chief Financial Officer

Date: ~~August~~November 2214, 2016

4849

EXHIBIT INDEX

2.1	Agreement and Plan of Merger, dated June 2, 2015, by and between Energy Telecom, Inc. and Energy Telecom Reincorporation Sub., Inc., filed as an exhibit to the Current Report on Form 8-K, filed with the Securities and Exchange Commission (“Commission”) on June 26, 2015 and incorporated herein by reference.
2.2	Agreement and Plan of Merger, dated June 30, 2015, by and between PFO Global, Inc., PFO Acquisition Corp., and Pro Fit Optix Holding Company, LLC, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 6, 2015 and incorporated herein by reference.
4.1	Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 26, 2015 and incorporated herein by reference.
10.1	Securities Purchase Agreement, dated July 8, 2016, by and between PFO Global, Inc. and Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 14, 2016 and incorporated herein by reference.

10.1*	Non-Qualified Stock Option Agreement, dated as of December 10, 2015, by and between the Company and Rudolf Suter.
10.2	Debenture, dated July 8, 2016, issued by PFO Global, Inc. to Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 14, 2016 and incorporated herein by reference.
10.2*	Consulting Agreement, dated as of April 1, 2016, by and between the Company and Rudolf Suter.
10.3	Letter Agreement, dated July 8, 2016, by and between PFO Global, Inc. and Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 14, 2016 and incorporated herein by reference.
10.3*	Non-Qualified Stock Option Agreement, dated as of April 1, 2016, by and between the Company and Rudolf Suter.
10.4	Securities Purchase Agreement, dated August 16, 2016, by and between PFO Global, Inc. and Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 19, 2016 and incorporated herein by reference.
10.4	Debenture, dated April 14, 2016, issued by PFO Global, Inc. to Hillair Capital Investment L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on April 15, 2016 and incorporated herein by reference.
10.5	Debenture, dated August 16, 2016, issued by PFO Global, Inc. to Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 19, 2016 and incorporated herein by reference.
10.5	Securities Purchase Agreement, dated as of April 14, 2016, by and between PFO Global, Inc. and Hillair Capital Investment L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on April 15, 2016 and incorporated herein by reference.
10.6	Securities Purchase Agreement, dated September 15, 2016, by and between PFO Global, Inc. and Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on September 21, 2016 and incorporated herein by reference.
10.6	Securities Purchase Agreement, dated as of June 13, 2016, by and between PFO Global, Inc. and Hillair Capital Investment L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 17, 2016 and incorporated herein by reference.

10.7 Debenture, dated June 13, 2016, issued by PFO Global, Inc. to Hillair Capital Investment L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 17, 2016 and incorporated herein by reference.

10.7	Debenture, dated September 15, 2016, issued by PFO Global, Inc. to Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on September 21, 2016 and incorporated herein by reference.

10.8*	Consulting Agreement, dated October 10, 2016, by and between PFO Global, Inc. and Brigitte Rousseau.

10.9	Securities Purchase Agreement, dated October 17, 2016, by and between PFO Global, Inc. and Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 21, 2016 and incorporated herein by reference.

10.10	Debenture, dated October 17, 2016, issued by PFO Global, Inc. to Hillair Capital Investments, L.P., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 21, 2016 and incorporated herein by reference.

31.1*	Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*	Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.1*	Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*	Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

4950

Filing Compare · PFO Global, Inc.